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ABSTRACT OF DISSERTATION 
 
 
 
 
MICROELECTRODE ARRAY RECORDINGS OF L-GLUTAMATE DYNAMICS 
IN THE BRAINS OF FREELY MOVING RATS 
 
 
 L-glutamate (Glu) is the predominant excitatory neurotransmitter in 
the mammalian central nervous system (CNS) and is associated with a wide 
variety of functions including motor behavior and sensory perception.  While 
microdialysis methods have been used to record tonic levels of Glu, little is 
known about the more rapid changes in Glu signals that may occur in awake 
animals.  We have previously reported acute recording methods using an 
enzyme-based microelectrode array (MEA) with fast temporal resolution (800 
msec), that is minimally invasive and is capable of detecting low levels of Glu (< 
0.2 µM) in anesthetized animals with little interference from other analytes.   We 
have made a series of modifications to the MEA design to allow for reliable 
measures in the brain of awake behaving rats.  In these studies, we 
characterized the effects of chronic implantation of the MEA into the striatum and 
prefrontal cortex (PFC) of Fischer 344 and Long Evans rats.  We measured 
resting levels of Glu and local application of Glu for 7 days without a significant 
loss of sensitivity and determined that Glu measures due to exogenous Glu 
varied between rat strain and brain region.  In addition, we determined the 
viability of the recordings in the brains of awake animals. We performed studies 
of tail-pinch induced stress which caused an increase in Glu in the striatum and 
PFC of Long Evans and Fischer 344 rats.  Histological data show that chronic 
implantation of our MEAs caused minimal injury to the CNS.  Taken together, our 
 data support that chronic recordings of tonic and phasic Glu can be carried out in 
awake rats reliably for 7 days in vivo allowing for longer term studies of Glu 
regulation in behaving rats. 
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Chapter One: Introduction 
 
Techniques for Studying L-Glutamate: Microelectrode Arrays vs. Microdialysis 
Historically, Glu neurotransmission has been studied in brain tissue using 
microdialysis and electrophysiological methods such as patch-clamp recordings 
(Bagley and Moghaddam, 1997; Fitzpatrick et al., 2001; Kennedy et al., 2002; 
Shou et al., 2004; Tucci et al., 1997).  Currently, the most common technique 
employed to study Glu levels in the intact mammalian brain is in vivo 
microdialysis.  Many microdialysis studies of Glu levels have been performed in 
anesthetized and awake animal models (Bagley and Moghaddam, 1997; 
Kennedy et al., 2002; Shou et al., 2004; Tucci et al., 1997).  Microdialysis allows 
for the simultaneous measurements of multiple analytes at low detection levels.  
However, the fast dynamics of Glu regulation may be muted when using 
microdialysis due to the limits in temporal resolution of this method. Progress on 
increasing the temporal resolution by coupling microdialysis with capillary 
electrophoresis (Tucci et al. 1997; Kennedy et al., 2002) has decreased sampling 
rates to every 12-18 seconds which is still far above the subsecond rates 
required.  In addition, several microdialysis studies have reported that the Glu 
overflow measured with this technique is not tetrodotoxin (TTX) -dependent, 
supporting the idea that the Glu signals measured using microdialysis are not 
neuronally derived (Timmermann and Westerink, 1997; Baker et al., 2002; 
Melendez et al., 2005).  Furthermore, it has been shown that there is extensive 
damage to the brain tissue up to 1.4 mm away from the microdialysis probe 
implant site (Clapp-Lilly et al., 1999; Borland et al., 2005) which may affect 
neurotransmitter signaling, release, and uptake.  Despite the incorporation of 
capillary electrophoresis, it is doubtful that microdialysis can achieve the 
temporal resolution required to see the subsecond dynamics of Glu, mainly due 
to the physical limitations associated with the diffusional process required to 
cross the dialysis membrane.  Since neurochemical levels and behaviors are 
capable of changing rapidly (sub-second), it is important to develop a technique 
that has an adequate temporal resolution.   
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Our laboratory has recently developed an enzyme-based microelectrode 
array (MEA) that is capable of selectively detecting low levels (0.2 µM) of Glu 
with sub-second (500 - 800 msec) time resolution that is virtually free from CNS 
interferents, such as 3,4-dihydroxy-phenylacetic acid (DOPAC) and ascorbate 
(Burmeister et al., 2000, 2003).  The present studies address the adaptation and 
validation of MEA recordings in the awake, freely moving rat, as well as address 
clinically relevant issues, such as measures of Glu resting levels, the effects of 
chronic implantation of the MEAs on surrounding brain tissue, Glu clearance, 
variance in phasic and tonic Glu between brain regions, and the effects of stress 
on Glu levels.  First, we adapted our methodology for chronic recordings of tonic 
(resting) levels and phasic (rapid) changes of Glu in awake rats.  Second, we 
investigated the reproducibility of such methods for chronic measures in the rat 
PFC and striatum over several days. Third, studies with pharmacological agents 
were carried out to better understand the specificity of these measures for Glu 
and the in vivo source(s) of these signals. Fourth, extracellular levels of Glu were 
investigated during a behavior related situation (stress induced by a tail-pinch) in 
the brain of awake rats.  Finally, we carried out histopathological studies to 
determine the damage produced by the MEA’s to surrounding brain tissue. 
 
L-Glutamate in the Mammalian Central Nervous System 
There are four main classification criteria for a neurotransmitter: 1) 
presynaptic localization, 2) release by a physiological stimuli, 3) identical action 
with naturally occurring transmitter, and 4) mechanism for rapid termination of 
transmitter action.  In the mid – 1980s, Glu met these criteria and was accepted 
as a candidate for a neurotransmitter (Krnjevic, 1986; Watkins, 1986).  Today we 
know that Glu is the predominant excitatory neurotransmitter in the mammalian 
CNS.  Glu has been shown to link many structures within the brain, including the 
cerebral cortex, hippocampus, basolateral amygdala, substantia nigra, nucleus 
accumbens, striatum, superior colliculus, caudate nucleus, red nucleus, and the 
pons.  Studies that examine the exact localization of Glu have been hard to 
accomplish successfully, mainly due to the abundance of Glu in the CNS and its 
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metabolic functions and the role of Glu as a precursor for γ-aminobutyric acid 
(GABA), the major inhibitory neurotransmitter in the brain.  Glu has been shown 
to play a role in development, plasticity, learning and memory, cognition, sensory 
systems, and motor systems through its interactions in the CNS.  In addition, Glu 
has also been associated with many brain disorders, including schizophrenia, 
addiction, stroke, traumatic brain injury, Huntington’s Disease, amyotophic lateral 
sclerosis, Parkinson’s Disease and epilepsy. 
For the scope of these studies, the brain areas of interest were the 
striatum and the PFC.  In the rodent, the medial PFC (infralimbic and prelimbic 
areas) is suggested to be the brain area responsible for executing function, 
including working memory (Aultman and Moghaddam, 2001; Delatour and 
Gisquet-Verrier, 1996; Floresco et al., 1996; Granon and Poucet, 1995; Kesner 
et al., 1996; and Seamans et al., 1995) and other cognitive functions.  All PFC 
efferents and the majority of the afferents to the PFC, such as projections from 
the thalamus, hippocampus, and amygdala, are glutamatergic.  Glu is also 
abundant in the striatum, which is important to these studies because the PFC 
and striatum send and receive input from each other and are interconnected via 
the limbic system and motor controls, which are implicated in various behavioral 
functions including the stress response.   
 
L-Glutamate Synthesis, Receptors, and Transporters 
Glu in the brain is derived almost entirely through local synthesis.  This 
may occur through multiple pathways.  In the brain, Glu is formed primarily 
through the Krebs cycle, by the transamination of α-ketoglutarate by Glu 
dehydrogenase, and also from glutamine derived from glial cells that can be 
converted in the nerve terminal to Glu via glutaminase.  A brief overview of the 
pathways mentioned here can be seen in Figure 1.1.  Glu in the nerve terminal is 
then transferred, via a highly specific Cl- -dependent vesicular Glu transporter 
(vGluT), and stored in synaptic vesicles until it is released into the synaptic cleft.  
In glutamatergic neurons, Glu is released through a calcium-dependent 
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exocytotic process where the synaptic vesicle fuses with the presynaptic 
neuronal cell membrane when the nerve terminal is depolarized.   
Once Glu is released into the synaptic cleft, the signal is terminated mainly 
by uptake into glial cells through high affinity sodium-dependent plasma 
membrane Glu transporters; the Glu aspartate transporter (GLAST-1) and Glu 
transporter-1 (GLT-1) (Danbolt, 2001; Fillenz, 1995).  Glu is then converted to 
glutamine and can be transported back to the presynaptic glutamatergic nerve 
terminal, where it can again be converted into Glu and stored in synaptic vesicles 
and used for release.  Glu near the synaptic cleft may also be terminated through 
uptake on the postsynaptic nerve terminal by a sodium-dependent plasma 
membrane excitatory amino acid carrier (EAAC).  Additionally, in the human 
brain, there are two more transporters, EAAT4 (cerebellum) and EAAT 5 (retina).  
As the primary area of interest for this document lies in the striatum and PFC of 
rats, EAAT4 and EAAT 5 will not be discussed.  A review of the primary location 
of Glu transporters in the rat brain can be found in Table 1.1. 
There are two types of Glu receptors, ionotropic (iGluR) and metabotropic 
(mGluR).  The iGluRs consist of α-amino-3-hydroxy-5-methyl-4-isoxazole 
propionate (AMPA), kainate, and N-methyl-D-aspartate (NMDA) receptors, 
named after select agonists.  The AMPA receptor is involved in the fast 
neurotransmission of excitation and utilizes sodium and Glu as endogenous 
agonists.  The NMDA receptor is involved in slow, prolonged neuronal 
depolarization.  This receptor is unique in that it requires two ligands, Glu and 
glycine, for receptor activation.  Additionally, the NMDA receptor is both ligand-
gated, using sodium, calcium, and Glu as endogenous agonists, and voltage-
gated due to the magnesium channel block.  A brief review of iGluRs can be 
found in Table 1.2. 
mGluRs are divided into three groups (I, II, and III).  mGluRs contain 
seven transmembrane spanning domains with their ligand-binding sites located 
on the extracellular N-terminus and are coupled to G-proteins.  mGluRs require 
subsequent second messenger signaling to elicit a response and are therefore 
generally slower acting than iGluRs.  The mGluR Group I (mGluR 1 and 5) are 
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linked to phospholipase C (PLC) and are generally excitatory.  While mGluR 
Group II (mGluR 2 and 3) and III (mGluR 4, 6, 7, and 8) act by inhibiting adenyl 
cyclase, and therefore cAMP formation, making mGluR Group II and III generally 
inhibitory.  mGluRs are thought to modulate brain excitability through their 
presynaptic, postsynaptic, and glial activity (Table 1.3).  As is evident from this 
brief discussion, the glutamatergic synapse is highly involved with its iGluRs, 
mGluRs, and transporters.  As such, Figure 1.2 outlines a typical glutamatergic 
synapse.   
 
The Role of Anesthesia on the Glutamatergic System in the Central Nervous 
System 
 The effects of anesthesia on the glutamatergic system in the CNS have 
only recently begun to be studied.  Various anesthetics may have widely differing 
effects on the glutamatergic system, based on their target of action.  One 
anesthetic of interest, isoflurane, a halogenated ether commonly used in the 
operating room, was first used clinically in 1981 affects Glu neurotransmission.  
Liachenko et al. (1999) reported inhibition by isoflurane on both the release and 
re-uptake of Glu with an EC50 in the clinical dose range.  Additionally, patch-
clamp recordings have shown a decrease in glutamatergic neuronal excitability 
with isoflurane.  However, these affects have been shown to return to normal 
within 30 minutes after the cessation of administration, making it a good 
candidate for use with humans as well as for recovery surgery with rodents.   
Another anesthetic commonly used when studying rodents is urethane 
due to its ability to produce a high plane of anesthesia for approximately eight 
hours without the need for re-administration.  While urethane is thought to have 
minimal effects on the dopaminergic system (Sabeti et al., 2003), little is known 
about its effects on the glutamatergic system.  Bindman et al. (1988) reported 
that there was no difference observed between in vitro brain slices and urethane-
anesthetized rats in resting membrane potential, action potential amplitude or 
membrane capacitance.  However, a diminished neuronal activity associated with 
urethane was observed in several studies (Albrecht and Davidowa, 1989; Dyer 
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and Rigdon, 1987; Girman et al., 1999).  Resting Glu levels in the anesthetized 
rat striatum were reported to be approximately 1.3 – 2.7 µM (Cellar, et al.,  2005), 
whereas, in an awake rat model resting Glu levels in the striatum were reported 
to be 0.20-0.82 µM (Di Cara et al.,  2001; Segovia et al.,  2001).  Additionally, 
microdialysis measures of resting Glu in the frontal cortex of the awake rat 
ranged between ~2 µM and ~9 µM (Baotell et al., 1995; Rocha et al., 1996).  
These discrepancies observed in resting Glu levels using microdialysis may be 
explained by differences in the sampling time employed, or the origin of the Glu 
pool being sampled, the brain region, as well as the effects of anesthesia.  It is 
entirely possible that there may be differences observed in tonic (resting levels) 
and phasic Glu levels in the brain as a result of the use or type of anesthetic. 
 
L-Glutamate in the Awake Animal Model 
Several methods have been employed to measure Glu in the awake rat 
model, including microdialysis.  However, none have the combined advantages 
of sub-second recording times, low levels of detection for Glu, and minimally 
invasiveness.  Recordings of Glu in freely moving animals have several distinct 
advantages.  First, this approach allows for monitoring Glu neurotransmission 
without the effects of anesthesia.   Anesthetics are known to alter resting levels 
and phasic Glu release dynamics (Liachenko et al., 1998, 1999).  Second, our 
microelectrodes can reliably record Glu for at least one week in the brain of the 
freely moving rat.  This means that subsequent measures can be made over 
multiple days rather than only one day as in anesthetized amperometric 
recordings as well as anesthetized and awake microdialysis studies.  Third, freely 
moving animal recordings can be coupled to behavioral studies to investigate 
changes in Glu that are due to behavior.  This allows us to directly couple a 
behavioral event with a physiological response.   
Of particular interest to us is the involvement of stress in neurological 
disorders, such as addiction, schizophrenia, and Parkinson’s disease.  Stress 
can play a major role in the development, progression and exacerbation of 
symptoms associated with these disorders (Carlsson and Carlsson, 1990; Grace, 
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1991; Greenamyre, 1993; Del Arco et al., 1998, 1999).  It has been suggested 
that Glu neurotransmission activation in the PFC is a common mechanism that 
may allow stress to influence both normal and abnormal processes that maintain 
cognition and affect (Moghaddam, 2002).  Glutamatergic neurotransmission in 
the PFC modulates or mediates many aspects of the stress response, such as 
activation of the hypothalamic-pituitary-adrenal (HPA) axis and monoamine 
neurotransmission.  Previous studies (Bagley and Moghaddam, 1997; Bland et 
al. 1999; Jedema and Moghaddam, 1994; Takahata and Moghaddam, 1998) 
have reported on stress response and Glu involvement in unanaesthetized 
animals, however, these studies did not have the temporal and spatial resolution 
that is possible with our ceramic MEAs and therefore, may not have detected the 
fast dynamics of Glu as a neurotransmitter.  In many psychiatric disorders, such 
as addiction, depression, and schizophrenia, stress appears to be a major 
influence in the course and outcome of the disease.  A better understanding in 
these areas may lead to more effective treatments. 
 
Thesis Outline 
As is evident from this discussion of the possible effects of anesthesia on 
the glutamatergic system and the techniques available for studying Glu in the 
awake animal, there is a great need to examine the glutamatergic system in a 
model that is free from anesthetics and has the capabilities to record low levels of 
Glu with high temporal resolution over long durations.  The work presented 
herein serves not only to develop and characterize a new technique designed to 
record Glu in the freely moving animal, but also to serve as a means to expand 
on the current knowledge of resting levels and behavior-evoked Glu in the awake 
rat.  In Chapter Three, we investigated resting Glu levels in the striatum and PFC 
of two rat strains, the Fischer 344 rat commonly used in age-related studies, and 
the Long Evans rat commonly used in behavioral based studies.  We 
accomplished this by using an enzyme-based ceramic microelectrode array 
configured to selectively measure Glu utilizing a self-referencing technique.  We 
determined resting Glu levels on days 3, 5, and 7 post-implantation prior to 
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stimulation.  We also examined potential mechanisms of action for regulating 
resting levels of Glu as well as the effect of urethane anesthetic on resting Glu 
levels.  Our results show that tonic Glu levels were significantly higher in the PFC 
of Long Evans rats compared to the PFC of Fischer 344 rats and the striatum of 
Long Evans rats and urethane significantly decreased tonic Glu levels (58%) in 
the PFC of Long Evans rats.  In addition, we showed that independent local 
application of TTX and mGluR2/3 agonist (LY379268) decreased resting Glu 
levels while the mGluR2/3 antagonist (LY341495) increased those levels.  Taken 
together, these results show that the pool of Glu being sampled was partially 
neuronally derived and was regulated presynaptically through mGluRs.  In 
addition, data showed that tonic Glu levels were significantly different between 
rat strains as well as brain regions and resting Glu levels decreased with 
urethane administration. 
Chapter Four further examines the glutamatergic system in the awake rat 
through local application of exogenous Glu and the differences observed in 
relation to time, brain region, and rat strain.  We showed that Glu measures from 
locally applied Glu were not significantly different throughout the first seven days 
post-implantation in a given brain region.  Additionally, exogenous Glu measures 
in the PFC of Long Evans and Fischer 344 rats were significantly increased 
compared to the striatum in the respective rat strain.  Also, exogenous Glu 
measures in the PFC were significantly increased in Long Evans rats compared 
to Fischer 344 rats.  However, no difference was observed in the striatum 
between the two rat strains.  These observations show that there were 
differences in the clearance of Glu between brain regions and rat strains.  These 
differences in clearance may be due to potential differences in brain tissue 
morphology, either the density of tissue or the type of cells present, or 
differences in the number, location, or efficiency of the Glu transporters.  We also 
examined changes in clearance in the PFC of Fischer 344 rats and observed a 
trend in increased clearance time associated with longer implant durations.  
These results also show that our enzyme-based ceramic MEA can reliably 
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measure Glu when chronically implanted in the brain for at least one week post-
implantation.   
In Chapter Five we examined the extent of damage, measured by 
astrocyte density and activated microglia, caused by chronic implantation of our 
ceramic MEAs in the PFC of Long Evans rats.  GFAP staining showed that there 
were no significant changes in astrocytes in rats with chronic MEA implantations 
for up to eight weeks.  However, at 16 and 24 weeks post-implantation there was 
a significant increase in GFAP density.  There was also a significant increase in 
mean density ionized calcium binding adaptor molecule 1 (Iba1) at the 1 week 
time point.  However, the Iba1 levels return to control levels by 24.  In all 
implantation durations examined, astrocytic changes indicating damage were 
contained to within 50-100 µm from the implantation site.  These results show 
that chronic implantation of our ceramic MEAs caused minimal damage to 
surrounding tissue and the electrode was well tolerated by the host for an 
extended length of time.  Furthermore, the results support that as we improve 
upon the technology and methodology of our enzyme-based coating, we will be 
able to extend the duration that we accurately and reliably measure Glu in the 
CNS.     
In Chapter Six we applied our newly developed technology in freely 
moving rats to a behavioral paradigm in an effort to enhance the current 
understanding of the affects of stress on Glu levels in the striatum and PFC of 
Fischer 344 and Long Evans rats.  Our results show that while there was no 
significant difference in the maximum Glu amplitude elicited between brain 
regions or rat strain, the duration of the Glu response observed in the striatum 
and PFC of Fischer 344 was significantly increased compared to that seen in the 
striatum and PFC of the Long Evans rats.  An analysis of the Glu response vs. 
time showed no significant difference in the tail-pinch response area under the 
curve.  However, there was a trend with the PFC showing elevated levels as 
compared to the striatum in both rat strains.  These results suggest that there 
may be multiple short-lived Glu peaks above the general rise and fall of the tail-
pinch response, not just a single maximum amplitude peak.  The number of 
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peaks during the tail-pinch response showed an increased trend in the PFC of 
both rat strains compared to the striatum.  This supports the need for a technique 
with high temporal resolution that is capable of distinguishing fast fluctuations in 
Glu coupled with advanced analytical techniques that can accurately depict 
changes of fast neurotransmitters, such as Glu.   
 
Copyright © Erin Cathleen Rutherford 2007 
 11
 
Table 1.1: Distribution of the Rat Brain Excitatory Amino Acid Transporters 
Transporter Subtype Primary Localization 
GLAST-1 Astrocytes 
GLT-1 Astrocytes 
EAAC Postsynaptic neurons 
EAAT4 Cerebellar Purkinje neurons (human) 
EAAT5 Retina (human) 
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Table 1.2: Ionotropic Glutamate Receptors 
Ionotropic Receptors  
NMDA AMPA Kainate 
Select Agonist NMDA AMPA Kainate 
Functional 
Characteristics 
Activation of NA+, 
K+, and Ca2+ 
channels 
Activation of 
NA+, K+, and 
Ca2+ channels 
Activation of 
NA+, K+, and 
Ca2+ channels 
Other Agonists Ibotenate, 
quinolinate 
Quisqualic acid Domoate, 
Competitive 
Antagonists 
2-AP5 CNQX, DNQX CNQX, DNQX 
Allosteric Modulators Glycine, 
D-serine 
Benzothiazide A 
(Con A) 
concanacalin 
Antagonists on 
allosteric binding 
sites 
5,7-diCl-Kyn   
Channel Blockers PCP, 
MK-801 
Jorospider toxin 
(JST) 
 
2-AP5, 2-amino-5-phosphonopentanoic acid; CNQX, 6-cyano-7-nitroquinoxaline-2,3-dione; 
DNQX, 6,7-dinitroquinoxaline-2,3-dione; 5,7-diCl-Kyn, 5,7-dichlorokynurenic; PCP, phencyclidine; 
MK-801, dizocilpine. 
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Table 1.3: Metabotropic Glutamate Receptors 
G
ro
up
 II
I
G
ro
up
 II
G
ro
up
 I
Pre- and postsynaptic in neurons; negative 
modulation of glutamate
Gi, Go; 
decrease 
AC
mGluR8
Pre- and postsynaptic in neurons; targeted 
presynaptically to active zone of glutamate release
Gi, Go; 
decrease 
AC
mGluR7
Localized to retinal tissue; low expression in brain 
tissue
Gi, Go; 
decrease 
AC
mGluR6
CPPG
MAP4
L-AP4
L-SOP
PPG
3,4-DCPG is 
a selective 
mGluR8 
agonist
Pre- and postsynaptic in neurons; high expression 
levels in rat cerebellum
Gi, Go; 
decrease 
AC
mGluR4
Primarily postsynaptic in neurons and gliaGi, Go; 
decrease 
AC
mGluR3
EGLU
LY341495
LY307452
DCG-IV
2R,4R-APDC
LY354740
LY379268
Pre- and postsynaptic in neurons; high expression 
levels in rat forebrain
Gi, Go; 
decrease 
AC
mGluR2
MPEP 
(noncompetitive)
Primarily postsynaptic in neurons and gliaGq; 
increase 
PLC
mGluR5
CPCCOEt
(noncompetitive)
3,5-DHPG
quisqualate
primarily postsynaptic in neurons; activation 
enhances postsynaptic glutamatergic excitability
Gq; 
increase 
PLC
mGluR1
AntagonistAgonistsLocalizations and FunctionsCouplingReceptor
 
3,5-DHPG, 3,5-dihydroxyphenylglycine; CPCCOEt, 7-hydroxyiminocyclopropane[b]chromen-1a-
carboxylic acid ethyl ester; MPEP, 2-methyl-6-(phenylethynyl)-pyridine; DCG-IV, (2S, 2’R,3’R)-2-
(2’,3’-dicarboxycyclopropyl)glycine; 2R,4R-APDC, 2R,4R-4-aminopyrrolidine-2,4-dicarboxylic 
acid; EGLU, (S)-α-ethylglutamic acid; L-AP4, 1,2-amino-4-phosphonobutyrate; L-SOP, S-serine-
O-phosphate; PPG, (RS)-4-phosphonophenyl glycine; CPPG, (2S,2’R,3’R)-2-(2’,3’-
dicarboxycylcopropyl)glycine; MAP4, (S)-α-methyl-2-amino-4-phosphonobutanoic acid.
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Glia Cells and Astrocytes
Glutamatergic Neuron
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Transferase
Glutamate 
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Figure 1.1: Neuronal Glutamate Metabolism Schematic 
Schematic showing basic Glu metabolism and release at a glutamatergic synapse.  
Glutamatergic neurons release Glu derived from glutamine and the Krebs Cycle into the synaptic 
cleft.  Glu is taken up into glial cells where it is converted to glutamine.  Glutamine can then be 
transported to the glutamatergic neuron where it can be deamidated back into Glu and packaged 
into synaptic vesicles for release.  In glia, Glu from the Krebs Cycle can also be converted into 
glutamine and transported to glutamatergic neurons where it can be converted back into Glu for 
release.  Adapted from Waagepetersen et al., 2000. 
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Figure 1.2: Glutamatergic Synapse Schematic 
Schematic representation of a typical glutamatergic synapse.  Glu from the Krebs Cycle is loaded 
into synaptic vesicles by vGluTs.  The synaptic vesicles fuse with the neuronal membrane 
releasing Glu into the synaptic cleft.  Glu can be transported into postsynaptic neurons via EAAC 
and into glia via GLT-1 and GLAST-1. Glu in the synaptic cleft can induce downstream signaling 
via post-synaptic neurons through mGluRs (groups I, II, and III) as well as through iGluRs 
(NMDA, AMPA, and kainate).  Glu can excite or inhibit presynaptic neurons through mGluR 
groups I, II, and III.  mGluR group I and II as well as the cystine-Glu exchanger are located on 
glia.  GABAergic neurons, which can be influenced by mGluR group II and III, can also act on 
postsynaptic neurons through GABAA and GABAB receptors.  Adapted from Schoepp, 2001. 
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Chapter Two: Materials and Methods 
 
Microelectrode Array Design and Fabrication 
Our multisite microelectrodes were constructed in conjunction with Thin 
Films Technology, Inc. (Buellton, California).  In these studies, MEAs were 
produced with the desired recording site array layout (S2 microelectrode arrays 
consisting of four (two side-by-side pairs) Pt recording sites, each 15 x 333 µm).  
Microelectrode photographic masks were designed on a computer aided design 
program where arrays of 4 recording sites were arranged on templates.  A 2.5 x 
2.5 cm x 125 µm thick ceramic wafer (alumina, Al2O3, Coors Ceramic, Coors 
Superstrate 996) served as a substrate for the MEAs.  Ceramic was used for its 
ability to reduce cross-talk from adjacent connecting lines.  Ceramic also allowed 
for stereotaxic placement into tissues without flexing or breaking due to ceramic’s 
strong and rigid nature.   
The ceramic wafer was cleaned and a photoresist was spun onto the 
wafer.  Light passing through the photomask exposed the photoresist, 
transferring the microelectrode images onto the wafer.  Spaces for the recording 
sites, connecting lines and bonding pads were not exposed to light.  Unexposed 
photoresist was removed from the wafer using solvents.  Titanium (500 Ǻ thick) 
was sputtered onto the ceramic wafer that was covered with developed 
photoresist.  The titanium acted as an adhesion layer that helped the Pt adhere 
to the ceramic substrate.  The active recording metal layer, Pt, was sputtered 
onto the substrate (~1.5 μm thick) on top of the titanium adhesion layer.  Next, 
the developed photoresist and unwanted metals were removed with solvents 
resulting in the ceramic wafer covered only with the Pt recording sites and 
connecting lines.  Finally, a protective polyimide layer (2-4 μm thick) was applied 
using a second photomask step, leaving the 4 active Pt recording sites uncoated.  
The individual microelectrodes tips were cut out using a diamond saw, which 
produced highly polished edges for reduced tissue damage during implantation.  
The ceramic wafer with Pt recording sites was attached to a small printed circuit 
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board (PCB) that allowed for easy handling and modification for use in the freely 
moving rat.    
 
Microelectrode Preparation 
Exclusion Layer 
Microelectrodes were coated with an exclusion layer to block undesirable 
electrochemically active compounds that exist in high concentrations in the brain.  
The Pt recording sites were dip coated with the exclusion layer, Nafion® (an 
anionic Teflon® derivative with negatively charged sulfonic acid groups), which 
acted to repel anions, such as ascorbate and DOPAC (Burmeister and Gerhardt, 
2001).  This was accomplished by first aliquoting Nafion® into a 300 μl centrifuge 
tube.  The microelectrode tip was then lowered approximately half-way into the 
aliquot of Nafion® and rotated in a circle three times and the tip was pulled 
straight out of the Nafion® solution.  Microelectrodes were then placed in an oven 
at 165-175°C for five minutes to allow the Nafion® layer to cure on the tip.  
Microelectrodes were allowed to cool to room temperature for approximately 30 
minutes prior to enzyme coating. 
 
Enzyme-Based Microelectrode Design 
Enzymes provided a means to convert a molecule, such as Glu, that is not 
inherently electrochemically active and therefore not measurable by a 16 bit Fast 
Analytical Sensing Technology (FAST-16) recording system (Quanteon, LLC, 
Nicholasville, KY), into a reporter molecule, such as peroxide (H2O2), that is 
oxidizable at the Pt recording sites of the microelectrodes.  The current 
measured from the oxidation of peroxide generated during the enzymatic 
breakdown was directly proportional to the analyte (Glu) concentration.  
Microelectrode recording sites 1 and 2 (the lower pair) were coated with a 1% 
Glu oxidase (GluOx) coating solution.  In order to induce cross-linking of GluOx 
and increase the adhesion of GluOx to the Pt recording sites, glutaraldehyde 
(0.125%) and BSA (1%) were added to the GluOx solution.  To prepare the 
GluOx solutions, first, all proteins were brought to room temperature and 0.10 g 
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of bovine serum albumin (BSA) was dissolved by manual agitation in a 1.5 mL 
microcentrifuge tube containing 985 μl ddH2O.  Once dissolved, glutaraldehyde 
solution (5 μl) was added to the BSA mixture and manually mixed by inversion 
five times.  The solution was set aside for five minutes.  The BSA served as a 
matrix to protect the oxidase enzyme activity during immobilization.  Next, the 
BSA/glutaraldehyde mixture (9 μl) was added to a 300 μl microcentrifuge tube 
and 1 μl of the Glu stock solution (1 UI/μl) was added and mixed by pipette 
agitation.   
All enzymes were applied to the Pt recording sites by hand.  Solutions 
were drawn up into a 10 μl Gastight® Hamilton microsyringe and dispensed to 
form a single small droplet of solution at the tip of the microsyringe.  The droplet 
was briefly applied to the Pt recording sites under a dissecting microscope.  Two 
additional coats of enzyme were applied in the same way with one minute dry 
times between each coat.  The GluOx layer was required by our approach to 
measure Glu, as it caused the enzymatic break-down of Glu to α-ketoglutarate 
and H2O2.  When a potential of +0.7 V vs. a Ag/AgCl reference electrode was 
applied to the MEA, the reporter molecule, H2O2, was oxidized and donated two 
electrons and the resulting current was then amplified and recorded by the 
FAST-16 recording system.   
The advantage of using multisite microelectrodes was that a pair of 
recording sites were coated with the enzyme mixture and the adjacent sites were 
coated with the inactive protein matrix (BSA and glutaraldehyde) in the same 
manner as applying the enzyme mixture.  Our laboratory refers to this technique 
as “self-referencing”.  Microelectrode recording sites 3 and 4 (self-referencing or 
sentinel sites) were coated similar to sites 1 and 2, with the exception that the 
coating solution did not contain GluOx (Figure 2.1).  This means that sites 3 and 
4 recorded everything not repelled by Nafion® (any possible interferents, etc.) 
except Glu.  When the current from sites 3 and 4 were subtracted from the 
current on sites 1 and 2, the resulting signal was due solely to Glu (Burmeister 
and Gerhardt, 2001 & Burmeister et al., 2003).  The combination of the exclusion 
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layer and the self-referencing technique resulted in a microelectrode with minimal 
background noise and an increased selectivity for the analyte of interest, Glu.   
Once the enzyme and/or inactive protein matrix was applied, 
microelectrodes were stored at room temperature.  Enzyme-coated 
microelectrodes cured at room temperature for 48-72 hours prior to calibration 
and experimentation.  Complete curing increased enzyme layer adhesion to the 
microelectrode surface.   This provided increased sensitivity to Glu as well as 
increased the shelf-life of the microelectrodes.  If the enzyme/protein layers were 
not allowed to fully dry, they might have dissolved when put into solution or the 
brain and the maximum number of possible chronic Glu recording days may have 
been diminished.   
 
Reference Electrodes 
 Ag/AgCl reference electrodes were prepared by first stripping the Teflon® 
coated silver wire (0.08 in bare, 0.110 in coated; A-M Systems, Inc., Carlsborg, 
WA) ¼ inch on each end.  One of the stripped ends was soldered to a gold-
plated socket (Ginder Scientific, Ottawa, ON) for connection to the FAST-16 
headstage for freely moving recordings and the other end was coated with AgCl 
by placing the tip of the stripped sliver wire (cathode) into a 1 M HCl plating bath 
saturated with NaCl containing a Pt wire (anode) and applying 9 V DC current 
using a power supply to the cathode vs. the anode.  The applied potential 
attracted Cl- on the wire to form AgCl thus making the Ag/AgCl reference.  The 
plating potential was applied for approximately 10-15 minutes.   
 
Printed Circuit Board Modification 
The pedestal was the portion of the system that was chronically implanted 
on the rat’s head and contained the microelectrode.  The pedestal connected to 
the miniaturized rat hat, which contained the miniature 4-channel pre-amplifier 
that was connected to a low torque commutator.  The PCB was altered during 
MEA production to change the electrode PCB from the design used in slice and 
anesthetized animal recordings to a smaller design required for use in freely 
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moving animals. The resulting shorter paddle was termed “stub” (Figure 2.1).  
The stub MEA was designed to allow for future advances to the MEAs with up to 
16 individual recording sites.  The number of recording sites can be changed 
simply by using the same stub PCB and substituting a ceramic tip with a different 
configuration.  The ceramic-based Glu MEAs were prepared for freely moving 
recordings first by cleaning the MEA.  This was done by dipping the bottom 
portion of the ceramic electrode tip in filtered, stirred isopropyl alcohol for five 
minutes.  This was followed by a five minute wash with stirred ddH2O to aid in 
removing any residues from the recording sites.  The Pt recording surfaces were 
carefully wiped twice with Kimwipes® to further remove any residual particles that 
may be on the recording sites and would have hindered the adhesion of the 
enzyme matrix.  MEAs were dried for fifteen minutes at 105-115°C to ensure 
there was no residual water on the sites.  Next, the MEAs were coated with 
Nafion®, cured at 170 ºC for five minutes followed by applying the coating 
solutions (either containing or not containing GluOx) as described previously.    
 
Chronic Connector and MEA Attachment 
In order to attach the chronic connector to the modified MEA for freely 
moving recordings, connecting wires were prepared by first stripping both ends of 
30 AWG varnished copper wire (Radioshack).  One end of the copper connecting 
wire was soldered to a gold-plated socket (Ginder Scientific, Ottawa, ON).  The 
other end of the wire was soldered to the PCB for each of the four corresponding 
recording sites, using eutectic solder, a low heat soldering iron (200° C) and heat 
sinks to prevent heat transfer damage to the enzyme matrix on the Pt recording 
sites (Figure 2.1).   The PCB portion of the microelectrode was coated with water 
proof five-minute epoxy to secure the assembly and protect the interface from 
moisture.  The epoxy was allowed to dry for approximately one hour.  The gold-
plated socket ends of the reference and microelectrode wires were inserted into 
a 9 pin miniature connector (Ginder Scientific, Ottawa, ON) so that the sockets 
were completely encompassed by the connector.  The varnished copper wires 
were tucked around the miniature connector and the MEA tip was carefully 
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positioned parallel to the miniature connector.  Correct positioning of the MEA tip 
was essential for accurate stereotaxic placement in the brain.  Water proof five-
minute epoxy was used to secure the paddle and wires to the miniature 
connector, making sure that the exposed part of the sockets on the end of the 
connector closest to the microelectrode tip and wires were covered with epoxy to 
ensure that moisture did not penetrate the pedestal.  The completed assembly 
was allowed to air dry for at least 1 hour. 
 
Microelectrode Array /Cannula Assembly 
In order to locally apply small quantities of Glu and other pharmacological 
agents near the MEA tip, a 26-gauge stainless steel guide cannula with inserted 
dummy cannula (Plastics One, Roanoke, VA) was attached to the PCB so the tip 
of the dummy cannula, protruding 1 mm past the guide cannula, was aimed 
between the four recording sites at a distance of approximately 100 µm away 
from MEA tip.  This was accomplished by attaching modeling clay to the PCB 
and using the modeling clay to hold the guide cannula steady while it was 
positioned between the recording sites.  Once the guide cannula was properly 
positioned, it was held more firmly in place by applying melted Sticky Wax (Kerr 
Corp., Orange, CA) onto the PCB and encasing the modeling clay.  Since the 
MEAs were coated with Nafion® and once they have been soaked the tips had to 
remain wet to prevent cracking in the exclusion layer, the guide cannula were 
attached pre-calibration.  Local applications of Glu or drug solutions for local 
pharmacological studies of the CNS were performed through a 33-gauge internal 
cannula, which protruded 1 mm past the guide cannula. A stainless steel dummy 
cannula remained in the guide whenever the animal was not in the recording 
chamber (Figure 2.1). 
 
Electrode Calibration 
Pt recording sites on the microelectrodes may respond differently to 
peroxide and Glu, and therefore must be calibrated in vitro prior to chronic 
implantation to determine standard curves.  These calibrations were used to 
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equate a change in current from the oxidation of peroxide to a proportional 
change in Glu (analyte) concentration.  Calibration also allowed us to determine 
the individual Pt recording sites sensitivity and selectivity against ascorbic acid, a 
major interferent in the brain.  Constant potential amperometry was performed 
using a FAST-16 system designed for recording simultaneously from the four-
channel microelectrodes with a primary gain of 0.2 nA/V and secondary gain of 
10 X generating a final gain of 2 nA/V for all calibrations.   
Nafion® coated microelectrode tips were soaked in a solution of 0.05 M 
phosphate buffered saline (PBS) for at least one hour prior to calibration.  The 
soaking time allowed for better diffusion of analytes through the Nafion® layer as 
well as activation of the enzyme layer.  However, once the Nafion® coated MEA 
has been wet, it must remain in solution at all times.  If the soaked Nafion® 
coated MEA was allowed to dry, the Nafion® layer would crack, allowing 
interferents to pass through the exclusion layer, therefore, decreasing the 
selectivity of the Pt recording sites for Glu.   
After soaking the MEA tip for at least one hour, the tip of the modified 
MEA was placed in a continuously stirred solution of 0.05 M PBS (40 mL; pH 7.4) 
using a battery operated, portable magnetic stir plate (Barnant Co.).  A 
recirculating water bath (Gaymar Co.) was used to maintain a constant buffer 
temperature of 37ºC to allow the enzyme layer to function properly and to mimic 
physiological conditions.  The calibrations were operated at a constant applied 
potential of +0.7 V vs. a Ag/AgCl reference electrode, allowing approximately 15 
minutes prior to the addition of calibration solutions for the current to reach a 
stable baseline.  Calibrations were performed by achieving final buffer 
concentrations of 250 µM ascorbic acid and 20, 40, and 60 µM Glu through 
additions of aliquots of 20 mM ascorbic acid and 20 mM Glu stock solutions 
(prepared in ddH2O) and allowing for stable baseline conditions between each 
addition.  Also, after the final addition of Glu was added, two test substances, 2 
mM DA (2 μM, final beaker concentration) and 8.8 mM H2O2 (8.8 μM, final 
beaker concentration) (40 µL additions; made in ddH2O), were added.  The test 
substances were used to determine the relative response and sensitivity of the 
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individual Pt recordings sites on each MEA and if needed, could be used as a 
means to normalize the experimental data.  The test substances did not affect 
the calibration slope, or any calculations derived from the slope (Figure 2.2).  
Another test substance addition was performed when a new substance was to be 
used for local or systemic application experiments to ensure that the compound 
was not electrochemically active on the Pt recording surfaces at +0.7 V.  The 
FAST-16 system software recorded the current for each addition of analyte (Glu), 
created a calibration curve for each Pt recording site, and stored the slope of this 
calibration.  Selectivity ratios for Glu over ascorbic acid were calculated in 
addition to the slope (sensitivity), limit of detection (LOD), and linearity (R2) for 
MEA Pt recording sites coated with GluOx.  Due to the highly reproducible 
fabrication process of the MEA, Glu responses were extremely linear and were 
only used if linear regression curves fit with R2 ≥ 0.99.   
Sensitivity of the MEA corresponded to how well the change in Glu was 
measured.  The slope from the in vitro calibration was used to equate a change 
in current to a change in Glu concentration and can be applied to determine the 
Glu concentration in vivo. The slope was also used to calculate LODs, which 
were the main criteria used to select microelectrodes.  LOD is the limit of 
detection for the MEA and was defined as the analyte concentration that resulted 
in an electrode response that was equivalent to 3 times the background noise of 
the FAST-16 recording system.  This was a conservative determination of the 
lowest detectable change in analyte concentration that cannot be attributed to 
noise.  The LODs for our microelectrodes range from approximately 0.2 to 1.0 
μM, depending on the stability of the sites.  Our laboratory normally recommends 
using MEAs with LODs ≤ 1 μM, depending on the expected Glu response, 
with 0.2 µM being optimal. 
Selectivity refers to the ratio of the microelectrodes sensitivity for Glu over 
interferents, such as AA.  Selectivity was determined by dividing the Glu slope by 
the AA slope.  A MEA with a selectivity of 100:1 refers to a 100 μM concentration 
increase of AA results in an apparent 1 μM concentration increase in Glu, or that 
the MEA is 99% effective at blocking AA.  Selectivity ratios of 100:1 or greater 
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are ideal, however, selectivity ratios as low as 20:1 were still used and extremely 
effective since this ratio is not a linear correlation.  In vitro calibrations showed 
that slope and LOD values were not significantly different over 7 days (Figures 
2.3 and 2.4). 
 
Animal Preparation for Awake Freely Behaving Amperometric Recordings 
Male Long Evans or Fischer 344 (Harlan) rats 3-6 months of age at the 
time of surgery were used for all experiments.  Fischer 344 rats weighed 375-450 
g, while Long Evans rats weighed 400-600 g at the time of surgery. The animals 
were group housed in a 12 hour light/dark cycle with free access to food and 
water in the AAALACI-approved animal resource center at the University of 
Kentucky.  Animals were allowed at least 7 days to acclimate to the environment 
prior to any experiments.  All appropriate animal care (food, water, bedding, cage 
cleaning, etc.) was performed by the Animal Resource Center staff.  There were 
no procedures involving undue discomfort to the animals.  Following surgery, rats 
were individually housed under the same conditions.  Animal care was approved 
by the University of Kentucky Institutional Animal Care and Use Committee and 
was in accordance with the Guide for the Care and Use of Laboratory Animals.  
 
Electrode implantation 
Following a successful calibration of the microelectrode, rats were 
anesthetized with 2% isoflurane, and placed in a stereotaxic apparatus (Kopf 
Instruments, Tujunga, CA).  Animal body temperature was maintained at 37°C 
with an isothermal heating pad (Braintree Scientific, Braintree, MA).  The 
animals’ eyes were coated with artificial tears (The Buttler Company, Columbus, 
OH) to help maintain moisture and prevent infection.  All surgeries were 
performed in a Vertical Laminar Flow Workstation (Microzone Corp., Ottawa, 
ON), which filtered lab air through a HEPA filter.  Prior to incision, the skin 
directly on top of the animals head (between the ears and from just behind the 
eyes to the neck) was wiped with Betadine solution to keep the incision area 
clean and to prevent infection.  The skin on top of the rat’s head was reflected, 
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making as small an incision as possible. Three small holes were drilled in the 
skull in the opposite quadrants of where the MEA was implanted for placement of 
stainless steel skull screws.  A fourth hole was drilled contralateral from the 
recording site for insertion of the Ag/AgCl reference electrode (see above).  The 
animals underwent a 2 mm x 2 mm craniotomy and were implanted with a Glu 
selective MEA pedestal assembly into the right striatum (AP: +1.0 mm; ML: -2.5 
mm; DV: -4.3 mm vs. bregma) or the right prefrontal cortex (AP: +3.2 mm; ML: -
0.8 mm, DV: -4.5 mm vs. bregma), based on the coordinates from Paxinos and 
Watson (2005) with the incisor bar set so that the skull was level (-2.3 mm).  
Three small stainless steel screws (Small Parts, Inc) were threaded into the skull 
to serve as anchors and care was taken so that the tip of the screw did not touch 
the brain (Figure 2.5).  The assembly was secured with approximately four layers 
of dental acrylic (Lang Dental MFG, Wheeling, IL), taking care to cover as much 
of the MEA assembly as possible.  The dental acrylic had a smooth texture and 
care was taken to remove excess dental acrylic from the fur surface so as not to 
promote the rat to scratch its head.   
Following surgery, rats were placed in their cage and monitored until the 
rat recovered from anesthesia (rats were usually fully awake within 5-10 minutes 
after removing from isoflurane).  One subcutaneous injection of Rimadyl® 
(carprofen) sterile injectable solution (10 mg/kg) (Pfizer, New York) was 
administered immediately following surgery for post-surgery inflammation and 
pain.  Rats were allowed to recover for a minimum of two days prior to initial 
recordings.   
 
Awake Freely Behaving Recordings 
Recording Apparatus 
The recording apparatus consisted of a large wooden box with a 
Plexiglas® insert.  The recording headstage consisted of a round miniature 
connector with 5 connector pins (one connecting each of the four Pt recording 
sites and one connecting the Ag/AgCl reference electrode). The connector pins 
lead to the 4 channel low noise potentiostat (Rat Hat 4, Quanteon, LLC, 
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Nicholasville, KY), which once connected sat as close as possible to the animal 
in order to minimize noise artifacts.  The potentiostat created a potential 
difference between the microelectrode array and a reference electrode to 
carryout electrochemical recordings.  Connecting wires, encompassed by an 
insulator, lead to the low torque commutator at the top of the box.  The recording 
assembly hung from the top center of the box from a 12 lead commutator 
(Airflyte, Bayonne, NJ).  This allowed the animal to freely move to all areas of the 
box.  The outputs of the commutator were connected to the FAST-16 system 
where the electrochemical analog signals generated by oxidation reactions were 
amplified and then digitized in the FAST-16 microcomputer using a fast A/D-D/A 
board (National Instruments) (Figure 2.6).  In addition, control voltages for 
amperometric measurements were controlled by the data acquisition board.  The 
digitized second-by-second (1 Hz) representation of the data was then visualized 
and recorded using the FAST-16 software (Quanteon, LLC, Nicholasville, KY).  
Recorded files were exported to other Windows™ based applications, such as 
Excel™, for easier data processing.   
 
Recording protocol 
Typical recording sessions involved allowing the rat to freely roam around 
the recording chamber for ten minutes to acclimate to the surroundings before 
connecting the pedestal to the potentiostat.  Data acquisition was started and the 
rat underwent a minimum thirty minute acclimation period, or until baseline was 
stabilized, before an ejection cannula was inserted or animal 
manipulations/behavior studies were initiated.  At this point, resting, or basal, Glu 
measures were taken.  The ejection cannulae were only inserted on days when 
chemicals needed to be ejected.  After the ejection cannula was inserted 
(connected to a 10 µL Hamilton syringe), another acclimation period of ~ 30 
minutes was allowed so that baseline was again established.  Following this 
period, the effects of locally applied Glu, urethane injections (i.p.), or other 
compounds, or a 5 minute tail-pinch were studied for up to three additional hours.  
The volumes of locally applied Glu were kept constant at 1 µL.   
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Following completion of the experiments (after multiple days of 
recordings), rats were anesthetized with isoflurane and transcardially perfused 
with 0.9% saline followed by 4% paraformaldehyde.  The brain was removed and 
stored in 4% paraformaldehyde for three days followed by storage in 0.1 M 
phosphate buffer (10% sucrose) for sectioning and staining to confirm MEA 
placement and examining possible tissue damage.   
 
Histopathology 
Male Long Evans rats between the age of 3 and 6 months at the time of 
surgery were chronically implanted with pedestal microelectrodes as previously 
described.  Animals were then anesthetized with isoflurane and transcardially 
perfused after 1, or 3 days, 1, 2, 4, 8, 16, or 24 weeks. The brains were stored as 
previously described.  After rinsing in sucrose, cryostat sections (14 µm) were 
collected from the area of implantation. The sections were postfixed in acetone 
for 3 minutes prior to being processed for indirect immunohistochemistry. 
Antibodies used were raised against glial fibrillary acidic protein (GFAP anti-
mouse, diluted 1:400; Chemicon) as a marker for astrocytes and Iba1 (anti-
rabbit, diluted 1:1000; Wako Chemicals, Germany), a pan-microglia marker (Imai 
et al., 1996; Ito et al., 1998). Incubations were performed for 48 hours at 4°C. 
After washing, the sections were incubated in Alexa 488 and Alexa 594 
secondary antibodies (diluted 1:500, Molecular Probes) for 1 hour at room 
temperature. Antibodies were diluted in PBS containing 0.3% Triton-X. After 
additional rinsing the sections were mounted in 90% glycerin in PBS. Double 
labeling of GFAP and Iba1 were performed in sequence such that each type of 
antibody was applied one at a time. Sections were evaluated using image 
analysis and Improvision software. The densities of GFAP and Iba1 
immunoreactivities were calculated using NIH image software on binary images 
and expressed as mean grey density.  Mean values from four sections from each 
brain were analyzed using a one-way ANOVA followed by Tukey’s post hoc 
analyses.  All measurements were performed on blind-coded slices.  
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Drugs and Reagents 
 All chemicals were used as received unless otherwise stated.   
 
Electrode Preparation and Calibration 
Nafion® (5% in a mixture of aliphatic alcohols and water), BSA, 
glutaraldehyde, ascorbate, Glu monosodium salt, and 3-hydroxytrypamine HCl 
(dopamine, DA) were obtained from Sigma-Aldrich Corp. (St. Louis, MO). GluOx 
was purchased from Seikagaku America, Inc. (East Falmouth, MA). The 3% 
H2O2 solution was purchased from a local retailer. 0.05 M PBS was created using 
sodium chloride, sodium phosphate monobasic, and sodium phosphate dibasic 
obtained from Fisher Scientific.  The DA stock solution was prepared in 1% 
perchloric acid for prolonged stability. Glutaraldehyde was stored at -20 ºC. 
Special care was taken to ensure that the stock Nafion®, BSA, and 
glutaraldehyde solutions were only used for 1-2 months.  All solutions were 
prepared using distilled water, which was de-ionized using a Millipore® water 
treatment system. 
 
Intracranial Ejection 
 All solutions administered intracranially were prepared in 0.9% 
saline solution, adjusted to pH 7.4, and filtered prior to use through a sterile 
syringe filter (0.22 µm pore size, Costar, Corning, NY).  All components of the 5 
mM Glu, 0.9% saline solution, 4% paraformaldehyde, 0.1 M PB with 10% 
sucrose, were purchased from Fisher Scientific.  Tetrodotoxin (TTX) was 
obtained from Sigma-Aldrich Corp. (St. Louis, MO, USA). (S)-4-
carboxyphenylglycine (CPG) was obtained from Tocris Cookson Inc. (Ellisville, 
MO).  mGluR agonist (LY379268) and mGluR antagonist (LY341495) were 
obtained from Eli Lilly & Co. (Indianapolis, Indiana). 
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Anesthetics and Special Use Drugs and Chemicals 
Isoflurane, used as anesthetic for recovery surgery and perfusions, was 
obtained from Baxter Pharmaceutical.  Rimadyl®, used for post-operative pain 
and inflammation, was obtained from Pfizer. 
 
Data Analysis 
 The FAST-16 recording system saved amperometric data, time, and 
ejection data marks for all four recording channels.  Unless otherwise noted, 
calibration data, in conjunction with a modified spreadsheet program, was used 
to determine parameters for the signal differences recorded between data marks.  
Measures derived from the data file included maximum amplitude, measured 
from baseline to the peak concentration of the signal, the time in seconds, or 
duration, of the signal, and t80, or the time it takes for 80% of the signal to decay.  
Unless otherwise noted, ejection (local application) volumes remained constant 
at 1 µL.  Additionally, for stress-evoked Glu measures, area under the curve was 
calculated from the beginning of the tail pinch until the Glu levels returned to 
baseline measures.  An analysis of variance (ANOVA) with a Tukey’s post hoc 
test was used to analyze the significance of all data.  Significance was defined as 
p < 0.05. 
 
Copyright © Erin Cathleen Rutherford 2007 
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Figure 2.1: Freely Moving Microelectrode Design 
A) Stub PCB with attached ceramic tip, or the stub MEA.  B) Stub MEA with connecting copper 
soldered to stub at the positions for channels 1, 2, 3, and 4.  Gold-plated sockets are attached to 
the ends of the copper wire.  Only the varnished section of the copper wire is showing.  C) 
Photograph of the pedestal MEA consisting of the stub MEA, Ag/AgCl reference electrode, and 
miniature connector.  Epoxy was used to mount the stub MEA on the miniature connector.  D) 
Pedestal MEA with attached guide cannula.  Dummy cannula is inserted in the guide cannula and 
protrudes past the guide cannula.  The guide cannula is held in place with sticky wax.  E) 
Illustration showing a Nafion® coated self-referencing MEA.  Pt recording sites are 333 x 15 µm 
with 20 µm/100 µm spacing.  E1,2) Glu recording sites.  E3,4) Self-referencing sites.  Adapted  
from Rutherford et al., 2007.
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Figure 2.2: L-Glutamate Self-Referencing Microelectrode Array Calibration 
Representative tracing of a typical calibration of a self-referencing Glu selective pedestal MEA.  A 
single 500 µL addition of 20 mM ascorbate shows little to no change in current.  This was 
followed by three 40 µL  additions of 20 mM Glu yielding a linear increase in Glu response on the 
GluOx coated sites (channels 1 and 2) but not the self-referencing sites (channels 3 and 4).  DA 
(2 mM) and H2O2 (8.8 mM) were added (40 µL) as test substances and changes in current were 
measured on all four recording sites. 
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Figure 2.3: Slope Values for In Vitro Calibrations 
In vitro calibrations were performed on MEAs to determine their slope values over days.  MEAs 
were Nafion® coated and continuously soaked in 0.05 M PBS.  Slope values were not significantly 
different over 7 days of calibration.  
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Figure 2.4: Limit of Detection Values for In Vitro Calibrations 
In vitro calibrations were performed on MEAs to determine their LOD values over days.  MEAs 
were Nafion® coated and continuously soaked in 0.05 M PBS.  LOD values were not significantly 
different over 7 day calibrations.   
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Figure 2.5: Microelectrode Implantation Surgery 
Drawing of rat skull (left) and schematic of pedestal MEA implantation surgery in the right PFC of 
a Long Evans rat (right).  Three skull screws were threaded into the skull (blue), a hole was drilled 
for placement of the reference electrode (green), a separate larger hole in the shape of a 
rectangle was drilled for MEA placement and the skull section was removed.  Adapted from 
Paxinos and Watson, 2005.  
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Figure 2.6: Schematic Diagram of the In Vivo Freely Moving Recording System 
The pedestal MEA is implanted in to the rat brain.  When the MEA is connected to the FAST-16 
recording system, the signal travels from the implanted MEA to the pre-amplifier rat hat.  The 
signal then travels through the commutator, which is located at the top of the recording chamber, 
and finally in to the FAST-16 control box and PC workstation.  The commutator allows for the 
connecting wires to freely rotate as the rat moves throughout the recording chamber without 
hindrance.  Gold sockets from the miniamplifier/rat hat connect to the gold sockets embedded in 
the miniature connector of the pedestal to allow for continuous recordings.  Dental acrylic 
surrounds the implanted pedestal apparatus.  The rat is able to move to all areas of the recording 
chamber, performing everyday activities while Glu is simultaneously recorded from the CNS of 
the rat.  Rutherford et al., 2007. 
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Chapter Three: Resting L-Glutamate Measures in Awake Male Fischer 344 and 
Long Evans Rats 
 
Introduction 
 Resting Glu measures in awake animals have been established using 
microdialysis; however, this method may not be capable of detecting subtle 
second-by-second changes in neuronal Glu and the origin of the glutamatergic 
pool being sampled is controversial.  Additionally, resting levels may be altered 
through a variety of mechanisms, including the effects of anesthesia.  
Anesthetics, including urethane, have been shown to decrease neuronal activity 
(Albrecht and Davidowa, 1989; Dyer and Rigdon, 1987; Girman et al., 1999) 
while maintaining excitatory Glu-mediated synaptic signal transmission (Sceniak 
and MacIver, 2006).  More specifically, previous studies have reported on 
reduced tonic Glu levels in anesthetized preparations (Liachenko et al., 1998, 
1999).  Urethane, the anesthetic currently used in our laboratory for acute 
recordings, was initially used because it was believed to have minimal affects on 
DA signaling, also of interest to our laboratory.  However, little is known as to 
how urethane affects glutamatergic neurotransmission.  There is precedence that 
anesthetics affect Glu neurotransmission in vitro; isoflurane was shown to 
decrease activation of both NMDA and non-NMDA glutamatergic receptors as 
well as reversibly reduce field potentials (Ranft et al., 2004).   
Little is known about potential mechanisms involved in regulating resting 
Glu and Glu release, such as the role inhibitory autoreceptors play in Glu 
signaling.  There is evidence that supports the involvement of Glu receptors, 
specifically mGluRs.  Some mGluRs have been shown to act as inhibitory 
presynaptic autoreceptors (groups II and III) while others may be excitatory 
(group I) (Schoepp, 2001).  Additional glutamatergic factors that may be involved 
in regulating resting extracellular Glu levels are iGluRs, Glu transporters, and the 
cystine-Glu exchanger, all of which are commonly present at glutamatergic 
synapses.   
This study was aimed at determining resting Glu levels and the factors 
that influence these levels in the brain of awake behaving rats.  In these studies, 
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we examined the differences in resting Glu in the striatum and PFC of two 
different rat strains, Fischer 344 and Long Evans rats.  Additionally, we 
determined the effect of anesthesia on resting Glu levels and made direct 
comparisons between resting Glu in the striatum and PFC of the awake and 
anesthetized rats using an amperometric recording technique.  We also 
examined the influences of TTX, a sodium channel blocker, mGluR group II 
agonist and antagonist, and a cystine-Glu exchanger blocker on resting Glu 
levels.   
 
Methods 
 Animals were housed in the conditions described in Chapter Two.  Male 
Fischer 344 and Long Evans rats were between three and six months of age at 
the time of implantation surgery.  Surgical procedures, MEA implantation in the 
striatum and PFC, and recording procedures followed those outlined in Chapter 
Two.  Briefly, male Fischer 344 and Long Evans rats were implanted either in the 
striatum or PFC under isoflurane anesthesia and allowed to recover for two days 
prior to recording sessions.  On recording days, rats were allowed approximately 
ten minutes to acclimate to the recording chamber prior to establishing a 
connection between the implanted MEA and the FAST-16 recording system.  
Once a connection was established and recordings started, a sampling rate of 1 
Hz was maintained throughout the recording session.  After recording for 
approximately 30 minutes, or longer if needed, and baseline was established, a 
15 second interval was used to determine resting Glu levels.  Recordings 
continued for other experimental use, such as, local application of Glu.  Data 
analysis involved an ANOVA with a Tukey’s post hoc test.  Significance was 
determined at p<0.05.   
 
Results 
Resting Glu levels in awake rats were measured in the striatum and PFC 
of Fischer 344 and Long Evans rats using the self-referencing technique 
described above.  Briefly, the self-referencing site currents were subtracted from 
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the Glu recording site currents during unstimulated recordings (Figure 3.1).  We 
observed a highly significant difference in resting levels of Glu in the PFC (37.4 ± 
3.0 µM Glu; n=7) of Long Evans rats compared to resting measures in the 
striatum (5.8 ± 0.4 µM Glu; n=7) of Long Evans rats and measures in the striatum 
(10.4 ± 0.7 µM Glu; n=3) and PFC (9.8 ± 0.7 µM Glu; n=7) of Fischer 344 rats 
(Figure 3.2).  No other significance difference was observed in resting Glu levels 
in the striatum and PFC in the Fischer 344 and Long Evans rats.  A comparison 
with microdialysis in the awake rat on resting Glu levels in the striatum and PFC 
is shown in Table 3.1. 
 After verifying that our MEA recording system was able to reliably 
measure Glu in chronically implanted and behaving rats over multiple days 
(Figure 3.3), we wanted to determine the effects of anesthesia, specifically 
urethane, on resting Glu levels in the brain.  After verifying that the MEA was 
functioning properly by locally applying Glu (see Chapter 4), the rats were 
administered urethane (1.25 mg/kg, i.p.) as per our usual protocols for 
anesthetizing rats in our laboratory for acute in vivo amperometry measures (Day 
et al., 2006; Nickell et al., 2005).  In this study, the resting Glu levels significantly 
decreased by an average of 58% (resting measures of 35.3 ± 2.5 µM dropped to 
14.9 ± 3.1 µM; n=4; p<.001) in the 2.5 hours following the initial urethane 
injection (Figure 3.4).  Additionally, resting Glu levels in anesthetized Fischer 344 
rat striatum (1.4 ± 0.2 µM) and frontal cortex (1.6 ± 0.3 µM) were significantly 
decreased compared to resting Glu levels in the awake Fischer 344 rat striatum 
and PFC (Figure 3.5) as measured by enzyme-based amperometry 
(anesthetized data taken from Day et al., 2006). 
The effect of TTX was studied in the PFC of awake male Long Evans rats.  
TTX was determined to decrease resting Glu levels in the PFC of Long Evans 
rats on average approximately 25 % (Figure 3.6).  However, TTX did not 
completely diminish the resting Glu levels, as was observed in recordings in the 
anesthetized rat (Day et al., 2006).  These results showed that resting Glu levels 
in the PFC of awake Long Evans rats were at least partially neuronally derived.  
However, the resting Glu levels must also have other contributing components.  
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For this reason, we wanted to determine the effects of (S)-4-
carboxyphenylglycine (CPG) on resting Glu levels.  CPG has been reported to be 
a cystine-Glu exchanger blocker (Baker et al., 2002; Melendez et al., 2005) as 
well as a competitive group I mGluR antagonist/weak group II mGluR agonist 
(Tocris Bioscience, Ellisville, MO).  This would suggest that when locally applying 
CPG, there should be an observed decrease in resting Glu levels.  However, 
upon local application of CPG in the PFC of awake Long Evans rats, we 
observed a rapid, robust increase in Glu with the spike lasting approximately 2 
minutes, followed by a prolonged slight decrease in Glu levels, lasting 
approximately 15 minutes (Figure 3.7).  Additionally, group II mGluR agonist and 
antagonist were examined for their effect on resting Glu levels.  The agonist 
(LY379268) decreased resting Glu levels 3.0 ± 0.4 µM below basal levels while 
the antagonist (LY341495) increased resting Glu levels 13.8 ± 4.7 µM above 
basal levels (Figures 3.8 and 3.9). 
 
Discussion 
The current self-referencing recording techniques with MEAs can be used 
to effectively and reliably measure resting (tonic) Glu levels.  Our data show that 
there was a significant difference in resting Glu levels between the striatum and 
PFC in Long Evans rats as well as between the PFC of Ficher 344 and Long 
Evans rats.  Direct comparisons to previous studies performed in our laboratory 
using the same method for detecting Glu have reported that the resting Glu 
levels in the frontal cortex of the anesthetized Fischer 344 rats were 1.6 ± 0.3 µM 
and in the striatum they were 1.4 ± 0.2 µM (Day, et al., 2006), or on average 
approximately 84% to 87% decreased compared to our freely moving Fischer 
344 recordings.  The differences observed in resting Glu between the 
anesthetized and awake rat were not surprising.  Studies using microdialysis 
report resting Glu in the anesthetized rat striatum to be approximately 1.3 – 2.7 
µM when sampling 20-24 seconds, which is comparable to our value of 1.4 µM 
(Cellar, et al., 2005).  However, in an awake rat model using microdialysis 
measures in the striatum, resting Glu levels were reported to be 0.202-0.82 µM 
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when sampling every 15-20 minutes (Di Cara et al., 2001; Segovia et al.,  2001).  
Additionally, 10 to 20 minute microdialysis measures of resting Glu in the frontal 
cortex of the awake rat ranged between ~2 µM and ~9 µM (Baotell et al., 1995; 
Rocha et al., 1996; Table 3.1).  Resting Glu discrepancies using microdialysis 
may be explained by the sampling time and method, the extent of damage, and 
the origin of the Glu pool being sampled.  In addition, our faster sampling rates 
coupled with decreased tissue damage may have contributed to the observed 
higher resting Glu levels in the awake rat.  Westerink’s group (Oldenziel et al., 
2006a) has also reported an elevated resting Glu levels (18.2 ± 9.3 µM) in the 
striatum of anesthetized rats using an enzyme-based hydrogel-coated 
microsensor with an osmium-containing redox polymer.  However, previous 
studies using redox hydrogel-coated enzyme-based Glu biosensors were limited 
by their response time of 8-10 seconds (Belay et al., 1998; Oldenziel et al., 
2006a; Oldenziel et al., 2006b). 
There was no significant difference observed in resting Glu levels between 
the striatum and PFC of Fischer 344 rats.  This finding was similar to the lack of 
significant difference seen by Day et al. (2006) between the striatum and frontal 
cortex in anesthetized Fischer 344 rats.  However, there remains an 84-87% 
increase observed in the current awake Fischer 344 striatum and PFC studies 
compared to those observed in the anesthetized Fisher 344 rats by Day et al. 
(2006).  The biggest contributor to the increased resting Glu levels in the awake 
animal model is most likely due to the system being relieved from the 
suppressive effects caused by anesthesia.   
We hypothesized that observed differences in resting levels of Glu 
between the awake and anesthetized animals using our enzyme-based MEAs 
were largely due to an effect of the anesthetic (urethane) on resting Glu levels.  
We tested the effects of urethane on resting Glu by administering urethane to 
freely behaving rats using the same protocols used in anesthetized studies.  Our 
freely moving studies in the PFC showed a 58% decrease in resting Glu levels 
following urethane dosing.  The point at which there is a 58% decrease in Glu 
levels was the time point at which surgery would begin for typical anesthetized 
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recordings.  However, typical anesthetized recordings in our studies would occur 
following approximately 0.5-3 hours additional time allowing for a deeper plane of 
surgical anesthesia.  These data show that anesthetics affected resting Glu 
levels in the rat brain and contributed to the previous poor estimates of resting 
Glu levels.   
In anesthetized animals, TTX diminished resting Glu by approximately 
100% (Day et al., 2006), whereas in the awake animals, TTX decreased resting 
Glu by approximately 25%.  The current data supplemented with work in the 
anesthetized animal by Day et al (2006) suggests that, while both the 
anesthetized and awake animal models exhibit resting Glu levels that are at least 
in part sodium channel-dependent as shown by the TTX data, anesthesia may 
block or inhibit other pools of Glu that contribute to resting levels resulting in 
diminished resting Glu.  Additionally, the awake rat may have the capability to 
better clear TTX from the extracellular space compared to the anesthetized rat. 
Since, in the awake rat model, urethane anesthesia was observed to 
decrease resting Glu levels by 58% and TTX decreased resting levels 25% in the 
PFC, there must still be other contributors to resting Glu.  One possible 
mechanism contributing to resting Glu levels could be group II mGluR, which act 
as inhibitory autoreceptors.  This suggested that a mGluR group II agonist acting 
presynaptically would actually have an inhibitory effect on Glu release into the 
synaptic cleft.  The mGluR group II agonist (LY379268) was shown to decrease 
resting Glu levels by approximately 8 % in the PFC of Long Evans rats, 
supporting the idea that there may still be other mechanisms affecting 
extracellular Glu levels.   
Another mechanism proposed to regulate resting Glu levels was the 
cystine-Glu exchanger (Baker et al., 2002; Melendez et al., 2005).  This 
exchanger is located on glial cells and acts via uptake of cystine into the glia cells 
coupled with the release of Glu into the extracellular space.  CPG is thought to 
act by blocking the cystine-Glu exchanger.  As such, a decrease in extracellular 
Glu would be expected when CPG was applied.  Additionally, Tocris Bioscience 
reported CPG as a mGluR group I competitive antagonist and a weak mGluR 
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group II agonist, which when acting presynaptically on Glutamatergic neurons 
should induce a decrease in extracellular Glu.  However, we observed an 
unexpected initial increase in Glu.  The increase peaked within seconds at 
approximately 20 µM above resting Glu levels and the entire duration lasted 
approximately two minutes, and therefore, may not have been detected, or the 
response may have been muted, in previous microdialysis studies.  One 
explanation for the increase in Glu may be because the group II mGluR also 
resides on GABAergic neurons, and act to inhibit GABA release.  If this inhibitory 
action on GABA was increased via an mGluR group II agonist, it could lead to a 
decrease on the GABAergic inhibition on glutamatergic neurons.  Following the 
initial increase in Glu there was a prolonged decrease that averaged 
approximately 4 µM below resting Glu levels and lasted approximately 15 
minutes which was most likely the decrease observed in previous microdialysis 
studies.  A summary of the approximate decreases observed in resting Glu levels 
due to urethane, TTX, CPG and LY379268 can be seen in Table 3.2. 
Taken together, the data show that while resting Glu levels remained 
consistent over multiple days within a given brain region, there were differences 
between brain regions as well as rat strains.  We also determined that the Glu 
pool sampled using our technique is at least partially neuronally derived and that 
there are many factors located throughout the synapse that may influence Glu 
levels, including mGluRs and the cystine-Glu exchanger.  Furthermore, our 
results show that resting Glu levels were significantly decreased by the 
anesthetic urethane, promoting a need for studies in the awake, freely behaving 
animal model to have a more accurate knowledge about neurotransmitter 
function.   
 
Copyright © Erin Cathleen Rutherford 
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Table 3.1: Resting L-Glutamate Levels in Awake Rats as Measured with Microdialysis or 
Enzyme-Based Amperometry 
Rutherford et al.
manuscript in preparationLong Evans
enzyme-based 
amperometry37.4 ± 3.0 µM
Rutherford et al.
manuscript in preparationFischer 344
enzyme-based 
amperometry9.8 ± 0.7 µM
Boatell et al., 1995
J. Neurochem.
Sprague-
Dawleymicrodialysis~2 µM
Rocha et al., 1996
Epilepsy Res.Wistarmicrodialysis~8 µM
Rutherford et al.
manuscript in preparationLong Evans
enzyme-based
amperometry5.8 ± 0.4 µM
Rutherford et al.
manuscript in preparationFischer 344
enzyme-based
amperometry10.4 ± 0.7 µM
Segovia et al., 2001
Neurochem. Res.Wistarmicrodialysis0.64 ± 0.18 µM
Di Cara et al., 2001
J. Neurochem.Wistarmicrodialysis0.274 ± 0.072 µM
CitationRat StrainTechniqueResting Glu Concentration
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Table 3.2: Effects of Application of Urethane, TTX, CPG or LY379268 on Resting L-
Glutamate Levels 
~8LY379268
~11CPG
~25TTX
~58Urethane
Decrease from Resting Glu (%)Substance Tested
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Figure 3.1: Determination of Resting L-Glutamate Levels 
Representative tracing of GluOx coated recording site (red) and sentinel, or self-referencing site 
(black).  The difference between the GluOx and sentinel baselines is an indication of resting 
(basal) Glu.  Glu (5 mM, 1 µL) was locally applied (indicated by arrow) and detected using a self-
referencing MEA.  Taken from Rutherford et al., 2007. 
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Figure 3.2: Resting L-Glutamate Levels in the Striatum and Prefrontal Cortex of Fischer 
344 and Long Evans Rats 
Resting Glu levels were measured in the striatum and PFC of Fischer 344 and Long Evans rats.  
The striatum of Long Evans rats and the striatum and PFC of Fischer 344 rats were significant 
compared to the PFC of Long Evans rats (***p<0.001). 
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Figure 3.3: Resting L-Glutamate Levels in the Prefrontal Cortex of Awake Long Evans Rats 
Resting Glu levels were recorded on days 3, 5, and 7 post-implantation in the PFC of freely 
behaving Long Evans rats using the self-referencing recording technique (n=7).  Resting Glu 
levels were consistent up to one week post-implantation.   
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Figure 3.4: Effects of Urethane on Resting L-Glutamate Levels in the Prefrontal Cortex of 
Long Evans Rats 
Resting Glu levels were continuously measured in the PFC of Long Evans rats.  Rats were 
anesthetized during recordings with urethane (3 i.p. injections, 25 minutes apart, 1.25 g/kg total).  
Resting Glu levels decreased 58% over 2.5 hours (n=4; *p<0.05; **p<0.01; ***p<0.001).  Taken 
from Rutherford et al. 2007. 
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Figure 3.5: Resting L-Glutamate Levels as Measured by Enzyme-Based Microelectrode 
Arrays in Fischer 344 Rats 
Resting Glu levels in the striatum and PFC of awake (red) and anesthetized (blue) Fischer 344 
rats using the same enzyme-based self-referencing MEA recording technique (***p<0.001 vs. Str 
Awake; ###p<0.001 vs. PFC Awake).  Anesthetized data was taken from Day et al., 2006.
 50
 
Time (seconds)
3 µL 100 µM TTX
1 µM
300 secondsG
lu
ta
m
at
e 
C
on
ce
nt
ra
tio
n 
(µ
M
)
Local Application of TTX
0
50
100
*
%
 R
es
tin
g 
G
lu
ta
m
at
e 
Co
nc
en
tr
at
io
n
Resting 
Levels
TTX
G
lu
ta
m
at
e 
C
on
ce
nt
ra
tio
n 
(µ
M
)
G
lu
ta
m
at
e 
C
on
ce
nt
ra
tio
n 
(µ
M
)
%
 R
es
tin
g 
G
lu
ta
m
at
e 
Co
nc
en
tr
at
io
n
%
 R
es
tin
g 
G
lu
ta
m
at
e 
Co
nc
en
tr
at
io
n
 
Figure 3.6: Effects of Tetrodotoxin on Resting L-Glutamate Levels in the Prefrontal Cortex 
of Long Evans Rats 
Resting Glu levels were continuously measured in the PFC of Long Evans rats.  TTX (100 µM, 3 
µL) was locally applied (indicated by arrow).  Resting Glu levels decreased ~ 25% as indicated by 
the inset (n=4; *p<0.05). 
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Figure 3.7: Effects of (S)-4-Carboxyphenylglycine on L-Glutamate in the Prefrontal Cortex 
of Long Evans Rats 
Glu levels were altered due to local application of CPG (50 µM, 3 µL).  There was an initial rapid 
increase in Glu followed by a prolonged decrease in Glu.  The increase in Glu was significantly 
elevated over resting Glu levels (~12 µM; n=4;  *p<0.05).   
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Figure 3.8: Typical Changes in L-Glutamate with Local Application of a mGluR Agonist and 
Antagonist in the Prefrontal Cortex of Long Evans Rats 
Representative tracings of resting Glu levels continuously recorded in the PFC of Long Evans 
rats.  mGluR agonist (LY379268) and antagonist (LY341495) were locally applied (100 µM, 3 µL, 
as indicated by arrows).   
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Figure 3.9: Effects of mGluR Agonist and Antagonist on L-Glutamate Levels in the 
Prefrontal Cortex of Long Evans Rats 
mGluR2/3 agonist (LY379268) and antagonist (LY341495) were locally applied (100 µM, 3 µL).  
Resting Glu levels were altered due to local applications of mGluR2/3 agonist and antagonist.  The 
agonist decreased resting Glu levels by ~2 µM, while the antagonist increased resting Glu levels 
~12 µM (n=4; **p<0.01 vs. resting Glu levels). 
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Chapter Four: Do Measures of Exogenous Glutamate Change Over Time, 
Between Brain Regions, and Between Rat Strains in Awake Rats? 
 
Introduction 
 Many similarities exist between rat strains as to their basic neuronal 
circuitry.  The PFC is thought to be involved in executive functions, such as 
cognition, and the striatum is involved with motor function in both the Fischer 344 
and the Long Evans rats.  However, there are also many difference between rat 
strains.  The Fischer 344 rat has been used primarily in age-related studies, 
while the Long Evans rat is used primarily in behavior-related studies.  Another 
major difference between the strains is the Fischer 344 rat is inbred and albino, 
while the Long Evans rat is outbred and pigmented.   
The neuronal circuitry and cell density is known to vary between brain 
regions, however, little work has been done to establish the effects of these 
differences on extracellular Glu clearance between brain regions and rat strains.  
Glu clearance can be affected by many things, including the density of Glu 
transporters present in a given brain area, the effectiveness of the transporters, 
and the regional cell density (Segovia et al., 2001b).  Additionally, Glu uptake in 
the striatum has been shown to significantly decrease in aged rats compared to 
young adult rats (Nickell et al., 2006).  One way to evaluate Glu clearance is 
through local applications of exogenous Glu.  This allows for clearance to be 
studied independent of Glu release.  While studying the effects of exogenous Glu 
alone can not give definitive answers as to the cause of differences in Glu 
clearance between brain regions, it can give some insight into the differences 
that may exist and the changes that may occur over time.  
In the present study we examine the differences between extracellular Glu 
levels measured in the striatum and PFC of Fischer 344 and Long Evans rats 
due to the local application of 1 µL of 5 mM Glu.  Differences in these levels may 
be an indication of differences in clearance.  To examine this, t80 was determined 
for both brain regions in both rat strains.  Although t80 cannot definitively 
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determine the cause of the potential differences observed, it can be used to 
determine differences in Glu clearance kinetics.  
 
Methods 
Animals were housed in the conditions described in Chapter Two.  Male 
Fischer 344 and Long Evans rats were between three and six months at the time 
of implantation surgery.  Surgical procedures, MEA implantation in the striatum 
and PFC, and recording procedures followed those outlined in Chapter Two.  
Briefly, male Fischer 344 and Long Evans rats were implanted either in the 
striatum or PFC under isoflurane anesthesia and allowed to recover for two days 
prior to recording sessions.  On recording days, 3, 5, and 7 post-implantation, 
rats were allowed approximately ten minutes to acclimate to the recording 
chamber prior to establishing a connection between the implanted MEA and the 
FAST-16 recording system.  Once a connection was established and recordings 
started, a sampling rate of 1 Hz was maintained throughout the recording 
session.  After recording for approximately 30 minutes, or longer if needed, and 
baseline was established, a 33-guage internal cannula attached with connecting 
tubing to a 10 µL Hamilton syringe and filled with 5 mM Glu (isotonic; pH 7.2-7.4) 
was inserted into the guide cannula aimed among the four Pt recording sites on 
the implanted MEA.  A series of four, 1 µL ejections of 5 mM Glu were 
performed, allowing time between each one for baseline to be re-established.  
Data analysis involved an ANOVA with a Tukey’s post hoc test.  Significance was 
determined at p<0.05.   
 
Results 
The FAST-16 recording system allowed for reliable second-by-second 
recordings of Glu in the striatum and PFC of awake, freely behaving rats.  We 
were able to consistently implant the MEA assemblies and record Glu for as long 
as 3 weeks, reliable for 7 days, in the awake rats.  Glu recordings were verified in 
vivo by locally applying a Glu solution (5 mM isotonic, pH 7.4, 1 µL) with the use 
of the cannula directed among the 4 recording sites approximately 100 µm from 
 56
the microelectrode surface.  The Glu peaks produced by local application were 
robust and reproducible as can be seen in the representative tracing of the self-
reference subtracted local applications of Glu in the striatum of a Long Evans rat 
(Figure 4.1).  This measure was repeatable within animals, between animals, and 
over multiple days.  This self-referencing subtracting technique (Burmeister and 
Gerhardt, 2001) was also used to measure resting Glu levels as discussed in 
Chapter Three.   
Another method for verifying Glu signals in vivo was performed by locally 
applying Glu (1 µL) while recording at applied potentials of either +0.7 V or +0.2 
V versus an Ag/AgCl reference electrode.  A sharp, robust peak was observed 
with locally applied Glu recorded at +0.7 V vs. Ag/AgCl.  However, when Glu was 
applied while the microelectrodes were polarized at +0.2 V vs. Ag/AgCl, little to 
no change in signal was observed (n=4) (Figure 4.2).  Our prior studies have 
shown that H2O2 is oxidized primarily at +0.7 V vs. Ag/AgCl at the Pt recording 
sites (Pomerleau et al., 2004).  Thus, this approach demonstrated that the in vivo 
signal derived from Glu is converted to H2O2 by the enzyme layer. 
Based on the verification studies, we were assured that we were 
measuring Glu in the awake rat brain.  The self-referencing technique was 
employed throughout these studies used both to verify that we were measuring 
Glu and to ensure that our maximum amplitudes reported were produced by Glu.  
Locally applied Glu measures were studied in the striatum and PFC of Fischer 
344 and Long Evans rats.  Measured responses in the PFC of Long Evans rats 
were not significantly different over days 3, 5, and 7 days post-implantation 
(Figure 4.3).  However, responses observed in the PFC were significantly 
increased compared to the striatum within rat strains (Long Evans striatum: 17.3 
± 3.5 µM; Long Evans PFC: 53.0 ± 6.8 µM; Fischer 344 striatum: 8.7 ± 1.3 µM; 
Fischer 344 PFC: 26.9 ± 3.2 µM) (Figure 4.4).  Additionally, the PFC in Long 
Evans rats was significantly increased compared to the PFC in Fischer 344 rats.   
We were interested in Glu clearance in the brain and if it changed over 
time.  When locally applying exogenous Glu on days 3, 5, and 7 post-
implantation, we determined the time it took for 80% of the signal to decay, or t80.  
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There was no significant difference in t80 over days; however, we did observe a 
trend in increased t80 as the duration of the implant increased in the PFC of 
Fischer 344 rats (Day 3: 33.4 ± 12.4 seconds; Day 5: 42.1 ± 16.4 seconds; Day 
7: 72.7 ± 5.3 seconds) (Figure 4.5).  Additionally, there was a decreasing trend 
observed in the PFC of Long Evans rats (Day 3: 8.5 ± 3.5 seconds; Day 5: 6.1 ± 
0.8 seconds; Day 7: 5.5 ± 1.8 seconds) (Figure 4.6).  Because the maximum 
amplitudes from local application of 5 mM Glu were not significantly different in 
the striatum of Fischer 344 and Long Evans rats, we were able to make a direct 
comparison of Glu clearance in these animals.  The t80 in the striatum (6.8 ± 0.3 
seconds) of Fischer 344 rats was significantly faster compared to the striatum 
(18.2 ± 3.0 seconds) of Long Evans rats (Figure 4.7).  Additionally, a Glu 
clearance comparison was made between amplitude matched recordings from 
the striatum of anesthetized (5.9 ± 0.8 seconds) and awake Fischer 344 rats 
(anesthetized data is unpublished data from Dr. Justin Nickell).  There was no 
significant difference in t80 in the striatum of anesthetized rats compared to 
awake rats (Figure 4.8).   
 
Discussion 
This study demonstrates that chronic enzyme-based MEA recordings in 
the awake freely moving rat offers a robust method for monitoring Glu in vivo with 
minimal tissue damage at the site of implant.  Current microdialysis methods are 
limited in reliable temporal resolution (minutes) and are only capable of recording 
over a single day per animal in the anesthetized or unanesthetized rat models 
(Shou et al., 2004).  In our studies, we extend this recording capacity to one 
week, routinely.   
Locally applied Glu recordings in the striatum and PFC of Fischer 344 and 
Long Evans rats were reproducible in maximum amplitude from day 3 through 
day 7 post implant.  Signals due to locally applied Glu were also measured in the 
striatum of unanesthetized Long Evans rats.  In the striatum, Glu signals were 
reproducible through day 7, as in the PFC.  However, the average maximum 
amplitudes of the Glu signals were smaller compared to the PFC, supporting 
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potential differential regulation of Glu in the rat PFC vs. rat striatum in the Long 
Evans rat.  
When using in vivo amperometry, identifying the molecule of interest is 
frequently questioned.  First the ability of the enzyme-based MEA to differentially 
record for a specific molecule, in this case Glu was due to the high selectivity of 
the enzyme (GluOx) for its substrate (Glu).  Another way we addressed this issue 
was by varying the applied potential of the recordings.  The reporter molecule, 
H2O2, resulting from the enzymatic breakdown of Glu by GluOx was oxidizable 
predominately at +0.7 V vs. a Ag/AgCl reference electrode.  However, as we 
have shown, when one drops the applied potential to +0.2 V vs. a Ag/AgCl 
reference electrode, we lost the Glu signal because H2O2 was no longer oxidized 
at the surface of the MEA.  To further support the ability of our enzyme-based 
MEA to detect Glu, we included an important and unique feature of our MEAs; 
the simultaneous self-referencing of the measured signal.  By subtracting the 
signals obtained on the 2 adjacent sites (sentinel sites) that were not coated with 
GluOx from the signals obtained from the sites that measure Glu, we were able 
to ascertain that the resulting signal was derived from Glu.  All possible 
interferents being detected by the Pt sites and/or noise were subtracted out of 
the signal.    Thus self-referencing methods were employed throughout this study 
to ensure that resting levels and peak responses (maximum amplitude) were due 
primarily to changes in extracellular Glu levels.   
Additionally, we determined the time it took for 80% of the signal to 
decrease in the PFC of Fischer 344 rats on days 3, 5, and 7 post-implantation.  
Signals were amplitude matched within brain regions and rat strains and t80s 
were examined.  There was no significant difference in t80 over days in the PFC 
of Fischer 344 or Long Evans rats.  However, there was a trend observed in 
Fischer 344 rats with day 3 having the fastest t80 and day 7 having the slowest.  
These results show a trend in slower clearance over time which may suggest 
fewer glia surrounding the implantation site or an decrease in the number of 
transporters located on the glia.  However, a decreasing trend was observed in 
the PFC of Long Evans rats with day 7 having the fastest t80.  These results show 
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a trend in faster clearance over time which may be due to an increase in glia 
surrounding the implantation site or an increase in the number of transporters 
located on the glia.  Additionally, although a direct comparison cannot be made 
since the maximum amplitudes with volume matched local applications of Glu 
were significantly increased in the PFC of Long Evans rats compared to Fischer 
344 rats, the t80 values for the PFC of Fischer 344 rats were approximately 4-13 
fold increased compared to the Long Evans rats.  This seems counterintuitive.  
One would expect slower t80s to be associated with larger amplitudes.  
Additionally, amplitude matched samples were used to make a direct comparison 
in Glu clearance in the striatum of Long Evans and Fischer 344 rats.  Glu 
clearance was significantly faster in the in the striatum of Fischer 344 rats 
compared to Long Evans rats.  Taken together, these results suggest that there 
may be a difference in regulation of brain morphology and transporters between 
the two rat strains and that there may be further differentiation between the brain 
regions in the different rat strains.  However, when comparing Glu clearance in 
the striatum of Fischer 344 rats between awake and anesthetized rats, there was 
no significant difference.  These results suggest that while there are differences 
in Glu clearance that exist between rat strains and brain regions and the 
anesthetic urethane decreased resting Glu (Chapter Three), the urethane does 
not act on Glu levels through Glu clearance mechanisms.   
 
Copyright © Erin Cathleen Rutherford 
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Figure 4.1: Representative Tracing of Local Application of 5 mM L-Glutamate (1 µL) in the 
Striatum of a Long Evans Rat 
Representative tracing of locally applied Glu (5 mM, 1 µL) in the striatum of Long Evans rats.  Glu 
was locally applied (indicated by arrows) and detected using a self-referencing MEA.  Tracing 
shown is the result of subtracting the self-referencing site from the GluOx coated site.  Glu peaks 
were rapid, robust, and reproducible. 
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Figure 4.2 Local Application of L-Glutamate at +0.7 V and +0.2 V vs. Ag/AgCl Reference 
Electrode 
Glu (5 mM, 1 µL) was locally applied (indicated by arrows) with either +0.7 V or +0.2 V vs. a 
Ag/AgCl reference electrode.  At +0.7 V an increase in current (Glu) was observed.  However, at 
+0.2 V no signal was observed, indicating that we are measuring Glu at +0.7 V vs. a Ag/AgCl 
reference electrode.  Taken from Rutherford et al., 2007. 
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Figure 4.3: Local Application of 5 mM L-glutamate (1 µL) Days 3, 5, and 7 Post-Implantation 
in the Right Prefrontal Cortex of Long Evans Rats 
Glu (5 mM, 1 µL) was locally applied over days in the PFC of Long Evans rats.  There was no 
significant difference observed (n=7).  Taken from Rutherford et al., 2007. 
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Figure 4.4: Local Application of 5 mM L-glutamate (1 µL) Day 3 Post-Implantation in the 
Striatum and PFC of Fischer 344 and Long Evans Rats 
Glu (5 mM, 1 µL) was locally applied on day 3 post-implantation in the striatum (Str) and PFC of 
Fischer 344 (F344) and Long Evans (LE) rats.  Levels in the PFC of Long Evans rats were 
significantly increased as compared to the striatum of Long Evans rats and the PFC of Fischer 
344 rats.  The PFC of Fischer 344 rats was also significantly increased compared to the striatum 
of Fischer 344 rats (n=7 except Str F344 n=4; *p<0.05; **p<0.01). 
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Figure 4.5: t80 on Days 3, 5, and 7 Post-Implantation in the Prefrontal Cortex of Fischer 344 
Rats 
t80s over days following local application of Glu (5 mM, 1 µL) were calculated and analyzed in the 
PFC of Fischer 344 rats.  No significance was observed between t80 over days 3, 5, and 7 post-
implantation.  However, a trend was observed in elongated t80 duration associated with longer 
implant durations (n=7). 
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Figure 4.6: t80 on Days 3, 5, and 7 Post-Implantation in the Prefrontal Cortex of Long Evans 
Rats 
t80s over days following local application of Glu (5 mM, 1 µL) were calculated and analyzed in the 
PFC of Long Evans rats.  No significance was observed between t80 over days 3, 5, and 7 post-
implantation (n=7).   
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Figure 4.7: t80 in the Striatum of Long Evans and Fischer 344 Rats 
t80s in the striatum of Long Evans and Fischer 344 rats following local application of Glu (5 mM, 1 
µL, amplitude matched) were calculated and analyzed.  t80 in the striatum of Long Evans rats 
were significantly longer than those observed in the striatum of Fischer 344 rats (n=7 (LE); n=4 
(F344); *p<0.05). 
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Figure 4.8: t80 in the Striatum of Awake and Anesthetized Fischer 344 Rats 
t80s in the striatum of awake and anesthetized Fischer 344 rats following local application of Glu 
(5 mM, amplitude matched) using the same enzyme-based self-referencing MEAs were 
calculated and analyzed.  There was no difference in Glu clearance (t80) in the striatum of awake 
and anesthetized Fischer 344 rat striatum (n=4 (awake); n=5 (anesthetized)).  Anesthetized data 
is unpublished data from Dr. Justin Nickell. 
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Chapter Five: The Extent of Damage on Surrounding Tissue due to Chronic 
Implantation of the Microelectrode Array 
 
Introduction 
 Many devices have been established to study Glu in the mammalian CNS 
including patch-clamp methods, carbon fiber microelectrodes, hydrogel-coated 
microsensors, and microdialysis probes.  The ideal technique for measuring Glu 
in vivo is one that is minimally invasive, has the capability to chronically record 
Glu with low levels of detection and a high temporal resolution, and can record 
resting Glu levels.  These methodologies can address several of these issues, 
however, none can address all by themselves.  Patch-clamp methods allow 
membrane potentials associated with Glu to be measured in single cells, 
however, it is limited in its ability to be used in the whole animal over several 
days.  Carbon fiber microelectrodes are minimally invasive and can be used in 
the awake animal, but it is hard to determine true resting Glu levels since there is 
only one recording channel and therefore no sentinel electrode.  Microdialysis 
methods allow for low levels of detection, but produce damage up to 1.4 mm 
remote from the implant site and have slow response times (Tucci et al., 1997; 
Clapp-Lilly et al., 1999; Belay et al., 1998; Kennedy et al., 2002; Borland et al., 
2005).   
To address the need for a single technique with the capabilities to 
chronically record Glu in the CNS of awake animals with low limits of detection, 
high temporal resolution and the ability to record resting Glu levels, our 
laboratory has developed an enzyme-based multisite ceramic MEA that is light 
weight and has been used to routinely record in anesthetized animals (Nickell et 
al., 2005; Day et al., 2006).  This technology has been successfully translated 
into chronic use in the freely moving animal (Pomerleau et al., 2003; Hascup et 
al., 2006; Rutherford et al., 2007) with Glu recordings possible through day 23 
post-implantation and routinely through day 7 post-implantation without 
significant loss of sensitivity for Glu.  Additionally, successful H2O2 test have 
been performed in vivo through day 90 post-implantation, suggesting that as we 
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improve upon our coating procedure we will be able to extend the duration that 
we are able to reliably record Glu.   
As we extend the possible recording lifespan of our MEAs, it is important 
to establish the effects of chronic implantation on surrounding tissue.  While the 
ceramic MEA tip is small and minimally invasive, the issue of tissue damage 
associated with chronic implantation of our ceramic MEAs has not been studied.  
These experiments were designed to address this issue.  In this study, Long 
Evans rats were chronically implanted in the right PFC for either 1 or 3 days, 1, 2, 
4, 8, 16, or  24 weeks.  Following this time, animals were sacrificed and the 
brains were sectioned and stained for GFAP and Iba1 to determine changes in 
astrocytes and microglia levels surrounding the MEA implant site.     
 
Methods 
Animals were housed in the conditions described in Chapter Two.  Long 
Evans rats were between three and six months at the time of implantation 
surgery.  Surgical procedures, MEA implantation in the PFC, and 
histopathological studies followed those outlined in Chapter Two.  Briefly, male 
Long Evans rats were implanted in the PFC under isoflurane anesthesia and 
allowed to recover.  Following implantation surgery, rats were returned to the 
animal facilities and remained there for either 1 or 3 days, 1, 2, 4, 8, 16, or 24 
weeks.  At these time points, rats were briefly anesthetized with isoflurane and 
transcardially perfused with 4% paraformaldehyde.  Brains were extracted and 
stored in 4% paraformaldehyde for three days.  After three days, the storage 
solution was changed to 0.1 M phosphate buffer with 10% sucrose.  Brains were 
then sliced and stained with a marker for astrocytes (GFAP) or a marker for 
microglia (Iba1) (courtesy of Dr. Ingrid Strömberg at Umeå University, Sweden).  
Pedestal MEAs did not have an attached guide cannula and were coated with 
Nafion® only, no GluOx.  There were no recording sessions with these animals.  
Data analysis involved an ANOVA with a Tukey’s post hoc test.  Significance was 
determined at p<0.05.   
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Results 
 MEAs were chronically implanted in to the right PFC of Long Evans rats.  
Following 1 or 3 days, 1, 2, 4, 8, 16, or 24 weeks rats were sacrificed and their 
brains were extracted and sectioned.  MEA placement in the PFC was verified 
with cresyl violet staining (Figure 5.1).  Brain sections were analyzed to 
determine the extent of damage on tissue surrounding the MEA implantation site 
by staining with Iba1 (microglia) and GFAP (astrocytes).  Mean densities for Iba1 
and GFAP were reported.  The shapes of the microglia were also examined to 
determine activation status.   
 GFAP staining was used to visualize astrocyte composition in the PFC of 
chronically implanted rats.  GFAP mean density surrounding the implant site was 
elevated at 3 days, 1, 2, 4, and 8 weeks compared to 1 day implants (3.83 ± 1.64 
mean density), however, a significant difference was only observed at 16 (39.47 
± 7.25 mean density) and 24 (33.60 ± 7.16 mean density) weeks post-
implantation (Figure 5.2).  Additionally, elevated GFAP staining was confined to 
within 50-100 µm surrounding the implantation site, regardless of the duration of 
the implant (Figure 5.3).  However, glial scaring was observed at the implant site 
in the 6 month implants (Figure 5.4). 
 Iba1 staining was used to visualize microglia composition in the PFC of 
chronically implanted Long Evans rats (Figure 5.6, left).  As seen with the GFAP 
staining, increased Iba1 staining was limited to within 50-100 µm of the 
implantation site.  The levels observed did not reach an astrocyte density that 
would be associated with an injury.  There was a dramatic increase in Iba1 
staining observed in the contralateral hemisphere of an eight week implant where 
a skull screw came into contact with the brain (Figure 5.6, right).  In rats 
implanted for 1 week (29.67 ± 5.50 mean density), there was a significant 
difference in Iba1 staining as compared to control hemispheres (10.30 ± 0.55 
mean density) and 1 day implants (9.32 ± 2.38 mean density).  However, the 
difference in Iba1 levels compared to control levels and 1 day implants returned 
to normal levels by 24 weeks (15.08 ± 3.86 mean density) with the implant 
(Figure 5.5).  Additionally, when analyzing the individual microglia cell type, there 
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were very few rounded, or activated, cells, supporting that our ceramic MEAs are 
well tolerated by the rat brain (Figure 5.4) (Laurenzi et al., 2002).   
 
Discussion 
 We investigated the histopathological effects from chronic MEA 
implantation.  The implantation durations of 1 and 3 days yielded similar findings 
for GFAP (astrocytes) and Iba1 (microglia) staining.  At close evaluation, both 
GFAP and Iba1 staining were seen to surround the MEA tracts, extending into 
tissue on average by 50 – 100 µm.  No further increase in staining was seen in 
adjacent areas to the MEA tracts.  There was a slight elevation observed in 
number of astrocytes immediately surrounding the site of implant that increased 
as the implant duration increased.  However, this elevation was not significant 
until 16 weeks with the implantation and did not extend more than 50-100 µm into 
the surrounding tissue.  These data correlate with Glu Clearance (t80) data 
(Chapter Four) obtained from the PFC of Long Evans rats on days 3 and 7 post-
implantation.  As the relative staining for astrocytes (the majority of high affinity 
Glu transporters are located on astrocytes – See Chapter One) increases, Glu is 
cleared more rapidly.  Furthermore the number of microglia was only significantly 
increased at 1 week (29.67 ± 5.50 mean density) post-implantation compared to 
control hemispheres (10.30 ± 0.55 mean density) and to 1 day (9.32 ± 2.38 mean 
density) implantations.  However, Iba1 levels returned to normal by 24 week 
implantations.  Figure 5.6 is an example of the microglia observed at the site of 
implantation and the degree of microglia activation that would be observed in an 
injury.  This was produced by a skull screw that was placed too deep and came 
into contact with the tissue.  Additionally, freely moving microdialysis studies yield 
a high degree of damage to the brain at the site of implant with extended damage 
observed up to 1.4 mm from the site of implantation within 30 hours (Clapp-Lilly 
et al., 1999; Borland et al., 2005).  By contrast, our MEAs did not disrupt brain 
tissue more than 50-100 µm from the microelectrode tracts and cell morphology 
remained healthy with normal processes and cell shape up to 24 weeks post-
implantation.   
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Additionally, pedestal MEA implants were cable of measuring H2O2 for up 
to 90 days in the awake, freely moving rat with no apparent adverse effects to the 
rat.  This suggests that as we improve upon our enzyme-based technology, 
through cross-linking and coating procedures, we will be able to increase the 
number of consecutive days we can record Glu in the unanesthetized animal.  
Furthermore, our H2O2 data support that the loss of ability to record Glu is due to 
an enzyme coating related function, not due to loss of MEA function.  The ability 
to record H2O2 longer than it is possible to detect Glu suggests that the enzyme 
layer may either be degrading or the enzyme may be dysfunctional (Valdes and 
Moussy, 2000) or detaching from the surface of the MEA.  However, this must be 
further analyzed to determine the exact cause of the loss of enzyme function. 
Current microdialysis studies report significant damage to brain tissue 
within 45 hours upto 1.4 mm of the area surrounding the probe implant site 
including altered mitochondria and endoplasmic reticulum.  This supports an 
intracellular chemical disruption in the neuronal processes, in addition to an 
observed neuronal density loss up to 400 µm away from the microdialysis implant 
site (Clapp-Lilly et al., 1999).  Additionally, Borland et al. (2005) observed 
disrupted dopamine release and uptake at least 220 µm remote from the 
microdialysis probe approximately 2 hours following probe placement.  However, 
histological studies performed to examine the effects of chronic implantation of 
our MEA showed minimal damage (50-100 µm) on surrounding brain tissue up to 
8 weeks post implant as measured by an astrocyte marker and one week as 
measured by a microglia marker with a return to control levels by 24-week post-
implantation.  The damage observed with chronic microdialysis implantations 
may account for the discrepancies between studies in terms of the source of the 
Glu measured.   
 
Copyright © Erin Cathleen Rutherford 
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Figure 5.1: Cresyl Violet Staining of Microelectrode Arrays Chronically Implanted in the 
Right Prefrontal Cortex of a Long Evans Rat 
Cresyl violet staining of neuropil.  MEA tract is clearly visible in the right PFC. 
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Figure 5.2: GFAP Staining of the Right Prefrontal Cortex of Long Evans Rats with Chronic 
Microelectrode Array Implantations   
Rats were sacrificed after 1 or 3 days, 1, 2, 4, 8, 16, or 24 weeks with the implanted MEA.  
Significance was vs. 1 day implantations (n=4; *p<0.05; **p<0.01).  Inset shows Glu clearance 
(t80) on days 3 and 7 post-implantation in the PFC of Long Evans rats.  Trend of faster Glu 
clearance correlates with trend of increased astrocyte density on days 3 and 7 post-implantation 
(n=7). 
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Figure 5.3: GFAP Staining of Right Prefrontal Cortex of a Long Evans Rat after an 8 Week 
Implant 
Image of the right PFC of a Long Evans rat after an 8 week implantation stained with GFAP.   
MEA tract is clearly visible.  Adapted from Rutherford et al., 2007. 
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Figure 5.4: Image of GFAP and Iba1 Staining in the Prefrontal Cortex of Long Evans Rats 
after 3 Day, 1 Week, 4 Week, and 24 Week Implantations 
Image of the control hemisphere (upper left) and implant site in the PFC of Long Evans rats after 
3 days, 1 week, 4 weeks or 24 weeks implant stained with GFAP (red) and Iba1 (green).  A glial 
scar can be seen along the MEA tract at 24 weeks. 
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Figure 5.5: Iba1 staining of the Right Prefrontal Cortex of Long Evans Rats with Chronic 
Microelectrode Array Implantations  
Rats implanted with pedestal MEAs were sacrificed after 1 or 3 days, 1, 2, 4, 8, 16, or 24 weeks.  
The contralateral hemisphere was used as controls (n=4; ***p<0.001 vs. 1 day; ^^^p<0.001 vs. 1 
week control).   
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Figure 5.6 :Iba1 Staining of the Right Prefrontal Cortex of a Long Evans Rat after an 8 
Week Implant 
Image of the right PFC of a Long Evans rat after an 8 week implantation stained with Iba1 (left).  
MEA tract is clearly visible.  Image of the contralateral hemisphere in a Long Evans rat after 8 
week implantation stained with Iba1 (right).  Increased GFAP staining is due to a stainless steel 
skull screw coming into contact with the brain and is indicative of an injury.  Adapted from 
Rutherford et al., 2007. 
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Chapter Six: Does Tail-Pinch Stress Affect L-Glutamate Levels in the Striatum 
and Prefrontal Cortex of Male Fischer 344 and Long Evans Rats? 
 
Introduction 
Stress can play a major role in the development, progression and 
exacerbation of symptoms associated with many disorders, including addiction, 
schizophrenia, and Parkinson’s disease.  It has been suggested that Glu 
neurotransmission activation in the PFC is a common mechanism that may allow 
stress to influence both normal and abnormal processes that maintain cognition 
and affect (Moghaddam, 2002).  The rodent medial PFC (infralimbic and 
prelimbic areas) is suggested to be the brain area responsible for executing 
function, such as working memory (Aultman and Moghaddam, 2001; Delatour 
and Gisquet-Verrier, 1996; Floresco et al., 1996; Granon and Poucet, 1995; 
Kesner et al., 1996; and Seamans et al., 1995) and other cognitive functions.  All 
PFC efferents and the majority of the afferents to the PFC, such as projections 
from the thalamus, hippocampus, and amygdala, are glutamatergic.  
Glutamatergic neurotransmission in the PFC modulates or mediates many 
aspects of stress response, such as activation of the hypothalamic-pituitary-
adrenal (HPA) axis and monoamine neurotransmission.  Glu is also abundant in 
the striatum which is involved in the limbic system and motor functions and as 
such, is connected to the PFC through various pathways.  Although the striatum 
is not commonly studied in conjunction with stress, the connection between the 
PFC and striatum present the striatum as another potential area to be influenced 
by stress.   
Previous studies (Gilad et al., 1990; Moghaddam, 1993; Jedema and 
Moghaddam, 1994; Bagley and Moghaddam, 1997; Takahata and Moghaddam, 
1998; Bland et al. 1999) have reported on stress response and Glu involvement 
in awake animals.  Microdialysis studies evaluating handling and swimming 
stress showed elevated Glu stress response in the PFC compared to the striatum 
(Gilad et al., 1990; Moghaddam, 1998).  Additionally, Glu response to stress was 
 80
shown to decrease with successive tail-pinch applications administered over a 
single day (Bagley and Moghaddam, 1997; Moghaddam, 2002).  However, these 
studies did not have the temporal and spatial resolution that is possible with our 
chronic pedestal microelectrode implants.   
In the present study we investigated the dynamics of Glu in response to 
tail-pinch stress in the PFC and striatum of Fischer 344 and Long Evans rats 
using our chronically implanted pedestal MEA.  We examined the duration, 
maximum amplitude, and fast dynamics of the Glu signal change due to a 
physiological event (tail-pinch stressor).  In addition, we were able to compare 
the changes in Glu response to stress in the striatum and PFC over multiple 
days.   
 
Methods 
Animals were housed in the conditions described in Chapter Two.  Male 
Fischer 344 and Long Evans rats were between three and six months at the time 
of implantation surgery.  Surgical procedures, MEA implantation in the striatum 
and PFC, and recording procedures followed those outlined in Chapter Two.  
Briefly, male Fischer 344 and Long Evans rats were implanted either in the 
striatum or PFC under isoflurane anesthesia and allowed to recover for two days 
prior to recording sessions.  On recording days 4 and 6 post-implantation, rats 
were allowed approximately ten minutes to acclimate to the recording chamber 
prior to establishing a connection between the implanted MEA and the FAST-16 
recording system.  Once a connection was established and recordings started, a 
sampling rate of 1 Hz was maintained throughout the recording session.  After 
recording for approximately 30 minutes, or longer if needed, and baseline was 
established, a five minute tail pinch stressor was performed by applying a 
clothespin approximately one inch from the base (where the tail meets the body) 
of the tail.  Data analysis involved an ANOVA with a Tukey’s post hoc test.  
Significance was determined at p<0.05.   
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Results 
Five minute tail-pinch stressors were performed while recording Glu 
signals on a second-by-second basis in Fischer 344 and Long Evans rats 
chronically implanted either in the striatum or PFC (Figures 6.1, 6.2, 6.3, and 
6.4).  We were able to measure changes in Glu due to physiological stimuli in the 
awake behaving rat.  Several parameters surrounding the tail-pinch were 
examined, including the duration of the tail-pinch response, the maximum 
amplitude of the tail-pinch, the area under the curve for the tail-pinch response, 
the number of peaks through out the tail-pinch response defined as a change of 
at least 15% over resting Glu levels, and the total peak area for the tail-pinch 
response.   
The duration of the tail-pinch response was defined as the time from the 
beginning of the tail-pinch until the Glu levels returned to baseline.  The duration 
of tail-pinch responses did not vary between brain regions within a single rat 
strain (either the Long Evans or Fischer 344 rats).  However, both the striatum 
(26.5 ± 9.8 µM) and PFC (27.5 ± 6.2 µM) in the Fischer 344 rats were 
significantly elevated (p< 0.05) compared to their counterparts in the Long Evans 
rats (striatum: 11.5 ± 2.4 µM; PFC: 13.6 ± 2.9 µM) (Figure 6.5).   
The maximum amplitude of the tail-pinch response was also examined. 
There were no significant differences observed between brain regions or rat 
strains.  This could be due to the large variation observed with the PFC (8.9 ± 4.3 
µM) and striatum (1.1 ± 0.4 µM) of the Long Evans rats and the striatum (7.9 ± 
6.4 µM) and PFC (4.9 ± 2.0 µM) of the Fischer 344 rats (Figure 6.6).  Similarly, 
when examining the area under the curve for the Glu tail-pinch response a large 
variance was observed in the PFC (8025 ± 4273 arbitrary units) and striatum 
(1061 ± 730.4 arbitrary units) of the Long Evans rats and the striatum (4648 ± 
4021 arbitrary units) and PFC (6795 ± 5209 arbitrary units) of the Fischer 344 
rats (Figure 6.7). 
To get a better understanding of the shape of the tail-pinch response, the 
number of peaks was analyzed.  There was no significance difference observed 
between rat strains or brain regions.  However, there was a trend of elevated 
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number of peaks during the tail-pinch response observed in the PFC of the Long 
Evans (31.0 ± 9.4 peaks) and Fischer 344 (12.7 ± 5.5 peaks) rats compared to 
the striatum of their respective counterparts (Long Evans: 17.6 ± 2.8 peaks; 
Fischer 344: 9.5 ± 1.5 peaks) (Figure 6.8).  Additionally, the total peak area for 
the tail-pinch response was analyzed.  The striatum (725.5 ± 497.2 arbitrary 
units) and PFC (4581 ± 2322 arbitrary units) in the Long Evans rats and the 
striatum (4497 ± 4117 arbitrary units) and PFC (6690 ± 5148 arbitrary units) in 
the Fischer 344 rats had a large degree of variance (Figure 6.9). 
 
Discussion 
Our laboratory was interested in stress and how it affects Glu levels in the 
striatum and PFC of Fischer 344 and Long Evans rats.  We wanted to determine 
if we could measure changes in extracellular Glu levels in a behaviorally relevant 
situation.  To examine this, we performed a five minute tail-pinch stress on 
Fischer 344 and Long Evans rats with chronic MEA implants in the striatum or 
PFC.  We observed large variations in tail-pinch response, even in an inbred rat 
strain (Fischer 344).  We also observed fast, robust Glu responses that would not 
be able to be seen when using conventional microdialysis.   
When analyzing the duration of the tail-pinch response, which we define 
as the beginning of the tail pinch and lasts until Glu levels return to resting levels, 
no significant difference was observed between the PFC and striatum within 
either the Long Evans or Fischer 344 rats.  However, there was a significant 
difference observed between the Fischer 344 and Long Evans rats in the PFC 
(27.5 ± 6.2 minutes and 13.6 ± 2.9 minutes, respectively; p<0.05), and in the 
striatum of Fischer 344 and Long Evans rats (26.5 ± 9.8 minutes and 11.5 ± 2.4 
minutes, respectively; p<0.05) with the response in the Fischer 344 rats lasting 
approximately two times those observed in the Long Evans rats.  The tail-pinch 
response in the Long Evans rats lasted approximately 10-15 minutes, regardless 
of brain area, whereas the duration of the tail-pinch stress response in the 
Fischer 344 rats was approximately 20-30 minutes (Figure 6.5), suggesting that 
Fischer 344 rats remained stressed longer.   
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The maximum amplitude was also examined and was defined as the 
maximum peak height in Glu response during the duration of the tail-pinch 
response.  There was no significant difference between the rat strains (Long 
Evans and Fischer 344) or between the brain regions (PFC and striatum) within 
the rat strains (Figure 6.6).  In an effort to examine possible differences between 
rat strains and brain regions in response to tail-pinch stress more accurately, we 
analyzed the data using area under the curve.  This method accounted for the 
duration of the Glu response to stress as well as the fluxuation of Glu response 
amplitudes throughout the duration of the Glu tail-pinch response.  There was no 
significant difference in the area under the curve for tail-pinch stress between rat 
strains or brain regions.  The averages for the area under the curve were 
decreased in the striatum of both rat strains compared to the PFC in the 
respective strains; however, the variance was too great to establish significance.  
The lack of significance suggests that there may be a regulatory mechanism in 
place in both the PFC and the striatum in the Fischer 344 and Long Evans rats 
that acts to limit the Glu response to stress such that over a period of time, there 
is a maximum total Glu concentration that can be achieved when the system is 
functioning properly.   
However, when analyzing the PFC and striatum, there was significance 
observed in the duration of the Glu response to tail-pinch stress in Fischer 344 
rats as compared to Long Evans rats, but no significance in either the maximum 
amplitude or the area under the curve.  The current data suggest that the 
striatum and PFC in the Long Evans rats must either have an increased number 
of spikes in Glu concentration or an elevated Glu undertone in response to tail-
pinch stress compared to the Long Evans rats.  To examine this possibility, the 
number of peaks during the tail-pinch response was analyzed (Figure 6.8).  
There was no significance observed in the number of peaks between brain 
regions or rat strains.  However, there was a trend with the number of peaks in 
the PFC of both rat strains having an increased average number of peaks as 
compared to the striatum in the respective rat strains (Figure 6.8).  Additionally, 
there was no significant difference in the total peak area between the rat strains 
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or brain regions.  Taken together, these data suggest that within a given rat strain 
and brain region there may be difference in the general rise and fall, or tone, of 
Glu.   
The durations of the responses to tail-pinch were well within the sampling 
range that can be observed using microdialysis.  Additionally, the maximum 
amplitudes observed using our recording technology would be detected using 
microdialysis.  However, current microdialysis studies lack the response time 
necessary to see the fast changes in peak amplitudes that we were able to be 
distinguished using our second-by-second recording capabilities.  Taken 
together, these studies support that the improved temporal resolution of enzyme-
based MEAs can be used for reliable second-by-second measures of Glu in the 
CNS of freely moving rats and recordings in awake animals are necessary to 
accurately determine the fast dynamics of glutamatergic function. 
 
Copyright © Erin Cathleen Rutherford 
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Figure 6.1: Representative Tracing of a Five Minute Tail-Pinch Response in the Striatum of 
a Long Evans Rat 
Long Evans rats implanted in the striatum underwent a five minute tail-pinch stressor.  Tail-pinch 
is indicated by the solid black line. 
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Figure 6.2: Representative Tracing of a Five Minute Tail-Pinch Response in the Prefrontal 
Cortex of Long Evans Rats 
Long Evans rats implanted in the PFC underwent a five minute tail-pinch stressor.  Tail-pinch is 
indicated by the solid black line. 
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Figure 6.3: Representative Tracing of a Five Minute Tail-Pinch Response in the Striatum of 
Fischer 344 Rats 
Fischer 344 rats implanted in the striatum underwent a five minute tail-pinch stressor.  Tail-pinch 
is indicated by the solid black line. 
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Figure 6.4: Representative Tracing of a Five Minute Tail-Pinch Response in the Prefrontal 
Cortex of Fischer 344 Rats 
Fischer 344 rats implanted in the PFC underwent a five minute tail-pinch stressor.  Tail-pinch is 
indicated by the solid black line. 
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Figure 6.5: Duration of Response to a Five Minute Tail-Pinch in the Striatum and Prefrontal 
Cortex of Fischer 344 and Long Evans Rats 
Fischer 344 (F344) and Long Evans (LE) rats were implanted in the striatum (Str) or PFC and 
underwent a five minute tail-pinch stressor.  The duration of the Glu response to the tail-pinch 
was examined.  Fischer 344 striatal responses were significantly increased compared to the 
striatum of Long Evans rats (*p<0.05).  Fischer 344 PFC responses were significantly increased 
compared to the striatum of Long Evans rats (#p<0.05) (n=7, except Str F344 n=4).   
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Figure 6.6: Maximum Amplitude during Tail-Pinch Response in the Striatum and Prefrontal 
Cortex of Fischer 344 and Long Evans Rats 
Fischer 344 (F344) and Long Evans (LE) rats were implanted in the striatum (Str) or PFC and 
underwent a five minute tail-pinch stressor.  The maximum amplitude of the Glu response to the 
tail-pinch was examined.  No significant difference was observed (n=7, except Str F344 n=4). 
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Figure 6.7: Area Under the Curve for Tail-Pinch Response in the Striatum and Prefrontal 
Cortex of Fischer 344 and Long Evans Rats 
Fischer 344 (F344) and Long Evans (LE) rats were implanted in the striatum (Str) or PFC and 
underwent a five minute tail-pinch stressor.  The area under the curve of the Glu response to the 
tail-pinch was examined.  No significant difference was observed (n=7, except Str F344 n=4). 
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Figure 6.8: Number of Peaks during Tail-Pinch Response in the Striatum and Prefrontal 
Cortex of Fischer 344 and Long Evans Rats 
Fischer 344 (F344) and Long Evans (LE) rats were implanted in the striatum (Str) or PFC and 
underwent a five minute tail-pinch stressor.  The number of peaks during the Glu response to the 
tail-pinch was examined.  No significant difference was observed (n=7, except Str F344 n=4). 
 
 
 
 
 93
 
Figure 6.9: Total Peak Area for Tail-Pinch Response in the Striatum and Prefrontal Cortex 
of Fischer 344 and Long Evans Rats 
Fischer 344 (F344) and Long Evans (LE) rats were implanted in the striatum (Str) or PFC and 
underwent a five minute tail-pinch stressor.  The area under the curve for the peaks during the 
Glu response to the tail-pinch was examined.  No significant difference was observed (n=7, 
except Str F344 n=4). 
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Chapter Seven: Preliminary Studies and Future Directions  
Much work has been accomplished to develop and characterize the 
enzyme-based ceramic MEA for use in freely behaving animal recordings.  Over 
the past several years there have been many advances in the freely moving 
recording system that have allowed us to optimize Glu studies in the awake rat.  
Our MEA design combined with our FAST-16 recording system has allowed for 
second-by-second measures of Glu.  A new paddle design allowed for Glu 
recordings on four independent Pt recording sites and that number will soon 
increase to eight.  Employing the self-referencing technique has allowed for 
measures of resting Glu levels and another way to verify that the analyte being 
measured is Glu.  Our laboratory has been successful in moving freely behaving 
Glu recordings into a mouse model, which with the use of transgenic mouse 
models will give us the opportunity to greatly enhance our knowledge of how the 
glutamatergic system works and the possibility to study disease models more in 
depth (Hascup et al., 2006).  Due to the nature of our enzyme-based MEAs, we 
are also capable of selectively measuring other analytes, such as dopamine and 
acetylcholine.  This chapter is a compilation of the various trials, preliminary 
studies, and future directions surrounding my work in the awake, freely behaving 
rat. 
In our initial studies (prior to the self-referencing capability) we wanted to 
determine if we could measure changes in Glu levels in a behaviorally relevant 
situation.  Our laboratory was interested in stress and how it affects Glu levels in 
the striatum.  Glu tracings of a typical tail-pinch stress in the striatum of Fischer 
344 rats can be seen in Figure 7.1.  The Glu response due to a 5 minute tail-
pinch yielded a bimodal response.  The initial phase was a rapid spike (A) lasting 
approximately 20 seconds.  The second phase (B) of the response had a plateau 
appearance with a sustained increase in Glu levels compared to baseline (n=3).  
These fast changes in Glu levels that occurred in the freely behaving rats due to 
stress would not be accurately detectable using other current in vivo techniques, 
such as microdialysis, for measuring Glu.  The prolonged plateau properties 
observed in the Glu signals due to stress is most likely the response observed in 
 95
current freely-moving microdialysis studies (Bagley and Moghaddam, 1997).  
Subsequent tail-pinches in the striatum of Fischer 344 rats resulted in a 
significantly decreased Glu response in both the spike (day 4 = 86.4 ± 7.5 µM vs. 
day 6 = 3.8 ± 1.9 µM) (Figure 7.2) and plateau portions (day 4 = 5.6 ± 0.1 µM vs. 
day 6 = 2.8 ± 0.1 µM; p<0.001) (Figure 7.3).  These studies in the striatum of the 
Fischer 344 rats were performed prior to having the capability to use the self-
referencing technique.  Therefore, the above results reported for the Fischer 344 
rat striatum tail-pinch stress data were reported as total Glu concentration and 
were not subtracted from sentinel sites.  The oscilloscope was used in all studies 
and only signals matched with valid oscilloscope data were used.  Taken 
together, these preliminary studies support that the improved temporal resolution 
of enzyme-based MEAs can be used for reliable second-by-second measures of 
Glu in the CNS of conscious freely moving rats and recordings in unanesthetized 
animals are necessary to accurately determine the dynamics of glutamatergic 
function.  
We also have preliminary data in the freely moving rat that shows locally 
applied DA results in robust, reproducible peaks (Figure 7.4).  Since DA was 
readily oxidized on our Pt recording surfaces, an enzyme coating was not 
necessary.  Instead, the MEAs were coated with the exclusion layer, Nafion®, as 
with our Glu configured MEAs, to block interferents including DOPAC and 
ascorbate based on charge, but still allowed for DA to reach the recording sites.  
Next, two of the Pt recording sites (either 1 and 3 or 2 and 4) were electroplated 
with another exclusion layer, meta phenylenediamine (mPD).  mPD formed a 
size exclusion layer that allowed molecules smaller than the matrix formed by 
mPD, such as H2O2, to pass through.  However, larger molecules, such as DA, 
were not able to pass through the mPD layer.  This coating procedure allowed 
oxidation of DA on the Pt recording sites that were only coated with Nafion®, but 
not on those coated with Nafion® and mPD.  Since mPD can be selectively 
electropolymerized onto a Pt recording site, we can utilize side-by-side self-
referencing for the DA selective MEA.  We were able to record resting DA levels, 
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DA signals due to locally applied exogenous DA, and evoked DA release due to 
a physiological event, a tail-pinch stress (Figure 7.5). 
The acetylcholine MEA relied on the same enzymatic principle established 
with the Glu configured MEA.  However, the acetylcholine MEA required 2 
enzymes, choline oxidase and acetylcholinesterase.  Neither choline nor 
acetylcholine is readily oxidized at +0.7 V and therefore, they require enzymatic 
breakdown to H2O2 to be measured by our FAST-16 recording system.  
Acetylcholinesterase breaks down acetylcholine into acetic acid and choline.  
Choline is then broken down by choline oxidase into betaine and H2O2, which 
can be oxidized at +0.7 V.  Again, by using the self-referencing techniques 
previously described for Glu selective MEAs, we were able to measure signals 
primarily due to acetylcholine.  When the self-referencing technique is applied to 
acetylcholine selective MEAs, the acetylcholinesterase and choline oxidase 
coated sites were the analyte measuring sites and the sites coated with choline 
oxidase, but not acetylcholinesterase, were the self-referencing sites.  Using this 
approach in the freely behaving rat, we were able to measure changes in 
acetylcholine due to tail-pinch stress (Figure 7.6).   
In addition to the tail-pinch stressor, our laboratory also wanted to 
examine the affects of another possible stressor, such as exposure to a natural 
predator, the fox.  To accomplish this, Glu was continuously recorded in the 
striatum of a Fischer 344 rat as previously described.  Once baseline was 
established, fox urine was applied to a cotton ball and placed in the recording 
chamber for 50 seconds.  We observed a delayed slight increase in Glu levels 
that immediately returned to baseline with the removal of the odor (Figure 7.7).  
The delay could be accounted for by the time it would take for the smell to reach 
all areas of the recording chamber.   
We also examined another brain area, the somatosensory cortex, for Glu 
response to a subcutaneous injection of a NMDA receptor antagonist (MK-801) 
and contralateral vibrissae stimulation.  There was no change in Glu levels in the 
somatosensory cortex associated with the injection of MK-801 (1 mg/kg).  
However, approximately 3.5 minutes after the MK-801 injection, the rat began to 
 97
seize (Figure 7.8).  There was an increase in Glu in the somatosensory cortex 
that correlated in time with the seizure.  When examining the affects of 
contralateral vibrissae stimulation on Glu in the somatosensory cortex a cotton 
tipped applicator was used to brush against the vibrissae for either 30 seconds or 
60 seconds.  Vibrissae stimulation resulted in an increase in Glu activity in the 
contralateral somatosensory cortex, but not an overall increase in Glu levels 
(Figure 7.9).   
Our laboratory also wanted to study the effects of circadian rhythm on 
glutamatergic function on a second-by-second basis.  This would give us the 
ability to monitor rapid changes that may occur during light and dark cycles in 
addition to the overall glutamatergic tone associated with these cycles.  
Additionally, with the capacity to measure in the awake behaving rat on a 
second-by-second time scale, we could couple our technology with an activity 
monitor to determine a direct association between activity level of the rat and 
changes in Glu levels.  An important first step was taken to pursue this merging 
of technologies.  We were able to continuously measure Glu in the PFC of a 
Long Evans rat for over 15 hours.  We observed an overall increase in resting 
extracellular Glu levels in the PFC of a Long Evans rat that was associated with 
the dark cycle, the time when rats are more active (Figure 7.10). 
Another area of interest is to combine the implantation of our MEAs with 
imaging techniques, such as magnetic resonance imaging (MRI).  This capability 
could open the door to many research avenues.  In addition to being able to 
determine tissue damage associated with chronic implant of our MEA, the ability 
to perform MRI guided implantation and recordings would allow us to strategically 
and accurately place the MEA in the brain area of interest and could allow us to 
record from small or hard to locate brain areas that would not be possible without 
guided placement.  A specific type of MRI, functional MRI (fMRI), in conjunction 
with MEA recordings would allow us to correlate changes in neurotransmitter 
levels with functional activation of specific brain areas.  We have taken a positive 
first step in being able to combine these two scientific methods.  We have brain 
images from a rat that underwent chronic implantation of our MEA.  The 
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implantation procedure followed those outlined in Chapter Two, except skull 
screws and guide cannula were not used since their metallic properties would 
interfere with the MRI scan.  After one day post-implantation, the rat was 
anesthetized with urethane to minimize their movement in the MRI scanner and  
was sacrificed following imaging.  Preliminary T1 MRI data showing images 
taken of the chronic MEA implantation clearly showed the tract from the 
implantation (Figure 7.11).    Additionally, the MRI scan revealed that there is 
little to no edema associated with chronic implantation of our MEA.  This 
supports our histopathological data of the chronic MEA implantations (see 
Chapter Five) which showed that our implantation materials and methods 
resulted in very little damage to the surrounding brain tissue as measured by 
GFAP (an astrocytic marker) and Iba1 (a microglial marker) that extended only 
approximately 50 – 100 µm into the tissue immediately surrounding the 
implantation site. 
Many of these preliminary trials and studies have laid the groundwork for 
future experiments.  We have been able to verify that by using our chronically 
implanted enzyme-based MEAs we are able to independently measure multiple 
analytes with our self-referencing technique.  However, an important advantage 
of microdialysis is the ability to measure multiple analytes simultaneously.  Our 
laboratory is in the process of developing MEAs with up to 36 recording sites.  
The additional recording sites will allow for multiple analytes to be measured 
using the self-referencing technique on a single MEA in a given brain area.  
These advances bring the promise of studies to evaluate neurotransmitter 
interactions in response to behavioral and chemical stimuli, such as the 
dopamine-Glu interactions that may exist in several brain areas, including the 
PFC and striatum. 
 
Copyright © Erin Cathleen Rutherford 
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Figure 7.1: Tail-Pinch Response in the Fischer 344 Rat Striatum 
Representative trace from the striatum of a Fischer 344 rats of a Glu response to a five minute 
tail-pinch.  The response was bi-phasic with an initial rapid spike in Glu followed by prolonged 
plateau-like Glu levels.  The duration of the tail-pinch is indicated by the solid black line. 
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Figure 7.2: Fischer 344 Tail-Pinch Striatal Spike Response 
Pedestal MEAs were implanted in the striatum of Fischer 344 rats.  Rats underwent a five minute 
tail-pinch stressor.  The maximum amplitude of the Glu response during the initial spike phase to 
the tail-pinch was examined.  The maximum amplitude of the spike response was significantly 
decrease during the second tail-pinch (TP2), which occurred on day 6 post-implantation, as 
compared to the first tail-pinch (TP1), which occurred on day 4 post-implantation (***p<0.001). 
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Figure 7.3: Fischer 344 Tail-Pinch Striatal Plateau Response 
Pedestal MEAs were implanted in the striatum of Fischer 344 rats.  Rats underwent a five minute 
tail-pinch stressor.  The maximum amplitude of the Glu response during the plateau phase to the 
tail-pinch was examined.  The maximum amplitude of the plateau response was significantly 
decrease during the second tail-pinch (TP2), which occurred on day 6 post-implantation, as 
compared to the first tail-pinch (TP1), which occurred on day 4 post-implantation (***p<0.001). 
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Figure 7.4: Local Application of Dopamine (200 µM, 1 µL) in the Striatum of a Long Evans 
Rat 
Single recording of locally applied DA (200 µM, 1 µL) in the striatum of Long Evans rats.  DA was 
locally applied (indicated by arrows) and detected using a self-referencing MEA.  Tracing shown 
is the result of subtracting the self-referencing site (Nafion® and mPD) from the Nafion® coated 
site.  DA peaks were robust and reproducible. 
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Figure 7.5: Dopamine Tail-Pinch Response in the Striatum of a Long Evans Rat 
Single DA recording of a five minute tail-pinch response from the striatum of a Long Evans rat.  
The duration of the tail-pinch is indicated by the solid black line. 
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Figure 7.6: Achetylcholine Tail-Pinch Response in the Prefrontal Cortex of a Long Evans 
Rat 
Single acetylcholine recording of a five minute tail-pinch response from the PFC of a Long Evans 
rat.  The duration of the tail-pinch is indicated by the solid black line. 
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Figure 7.7: Glutamatergic Response to Fox Urine Exposure in the Striatum of a Fischer 344 
Rat 
Single glutamatergic recording of a response to fox urine odor in the striatum of a Fischer 344 rat.  
The duration of the fox urine exposure is indicated by the solid black line. 
 
 
 106
 
Time (seconds)
 
5µM
60 seconds
G
lu
ta
m
at
e 
C
on
ce
nt
ra
tio
n 
(µ
M
)
 
G
lu
ta
m
at
e 
C
on
ce
nt
ra
tio
n 
(µ
M
)
 
Figure 7.8: Glutamatergic Response to a NMDA Receptor Antagonist (MK-801) in the 
Somatosensory Cortex of a Long Evans Rat 
Single glutamatergic recording of a response to a subcutaneous injection of MK-801 (1 mg/kg) in 
the somatosensory cortex of a Long Evans rat.  Arrow indicates induction of a seizure 
approximately 3.5 minutes following injection.   
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Figure 7.9: Glutamatergic Response to Contralateral Vibrissae Stimulation in the 
Somatosensory Cortex of a Long Evans Rat 
Single glutamatergic recording of a 30 second (left) and 60 second (right) contralateral vibrissae 
stimulation response from the somatosensory cortex of a Long Evans rat.  The duration of the 
vibrissae stimulation is indicated by the solid black line. 
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Figure 7.10: Continuous Second-By-Second Recording of L-Glutamate over Light and Dark 
Cycles 
Single continuous recording of resting Glu levels in the PFC of a Long Evans rat encompassing 
the light (non-shaded region) and dark cycle (shaded region).  Glu levels were elevated during 
the dark cycle as compared to the light cycle. 
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Figure 7.11: T1 MRI of an Implanted MEA in the Prefrontal Cortex of a Long Evans Rat 
A) Coronal view of a T1 MRI of a MEA implanted in the right PFC of a Long Evans rat.  B) 
Horizontal view of a T1 MRI of a MEA implanted in the right PFC of a Long Evans rat.  C) Sagital 
view of a T1 MRI of a MEA implanted in the right PFC of a Long Evans rat.  Arrows indicate MEA 
implant site. 
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